system for replacing a native heart valve

专利摘要:
SYSTEM FOR REPLACEMENT OF A NATIVE HEART VALVE. The present invention relates to a system for replacing a native heart valve. The system for replacing a native heart valve comprises an expandable helical anchor (30) formed as multiple spirals (32) adapted to support a heart valve prosthesis (10), a first spiral in a first diameter and being expandable to a second larger diameter by applying an outward radial force from within the helical anchor (30), whereby the expandable heart valve prosthesis (10) is capable of being sent to the helical anchor (30) and expanded within the multiple spirals (32) to move the first spiral from the first diameter to the second diameter, while the helical anchor (30) and the heart valve prosthesis (10) lock together.
公开号:BR112016002887B1
申请号:R112016002887-2
申请日:2014-08-11
公开日:2021-05-25
发明作者:Paul A. Spence；Landon H. Tompkins
申请人:Mitral Valve Technologies Sarl；
IPC主号:

专利说明:

CROSS REFERENCE TO RELATED ORDERS
[001] This application claims priority to U.S. Provisional Application Serial No. 61/864,860, filed August 12, 2013 (pending); U.S. Provisional Application Serial No. 61/867,287, filed August 19, 2013 (pending); and U.S. Provisional Application Serial No. 61/878,280, filed September 16, 2013 (pending), the disclosures of which are hereby incorporated by reference herein. TECHNICAL FIELD
[002] The present invention generally relates to medical procedures and devices relating to heart valves, such as replacement techniques and apparatus. More specifically, the invention relates to the replacement of heart valves having various malformations and dysfunctions. BACKGROUND
[003] Complications of the mitral valve, which controls blood flow from the left atrium to the left ventricle of the human heart, have been known to cause fatal heart failure. In the developed world, one of the most common forms of valvular heart disease is a mitral valve leak, also known as mitral regurgitation, which is characterized by an abnormal leakage of blood from the left ventricle through the mitral valve and back into the left atrium. This most commonly occurs due to an ischemic heart disease, when the mitral valve cusps no longer meet or close properly after multiple infarcts, idiopathic and hypertensive cardiomyopathies, in which the left ventricle enlarges, and with cusp abnormalities and such as those caused by a degenerative disease.
[004] In addition to mitral regurgitation, a mitral narrowing or stenosis is most often the result of rheumatic disease. Although this has been virtually eliminated in developed countries, it is still common where living standards are not as high.
[005] Similar to mitral valve complications are aortic valve complications, which control the flow of blood from the left ventricle to the aorta. For example, many older patients develop aortic valve stenosis. Historically, traditional treatment has been a valve replacement with a large open-heart procedure. The procedure takes a considerable amount of time to recover as it is highly invasive. Fortunately, in the last decade, great strides have been made in replacing this open-heart surgery procedure with a catheter procedure that can be performed quickly without surgical incisions or the need for a heart-lung machine to support the circulation while the heart is stopped. . Using catheters, valves are mounted on stents or structures such as stents, which are compressed and sent through blood vessels to the heart. The stents are then expanded and the valves begin to function. The diseased valve is not removed but is instead crushed or deformed by the stent, which contains the new valve. The deformed tissue serves to help anchor the new prosthetic valve.
[006] The delivery of valves can be performed from arteries, which can be easily accessed in a patient. Most commonly, this is done from the groin, where the femoral and iliac arteries can be cannulated. The shoulder region is also used, where the subclavian and axillary arteries can also be accessed. A recovery from this procedure is remarkably fast.
[007] Not all patients can be served with a pure catheter procedure. In some cases, the arteries are also too small to allow catheters to pass into the heart, or the arteries are too diseased or crooked. In these cases, surgeons can make a small incision in the chest (thoracotomy) and then place these catheter-based devices directly into the heart. Typically, a purse string suture is placed at the apex of the left ventricle, and the delivery system is passed through the apex of the heart. The valve is then sent to its final position. These delivery systems can also be used to access the aortic valve from the aorta itself. Some surgeons introduce the aortic valve delivery system directly into the aorta at the time of open surgery. Valves vary considerably. There is a mounting frame that is often a form of stent. The prosthetic cusps are carried within the stent in a mounting and retention framework. Typically, these cusps are made from a biological material that is used in traditional surgical valves. The valve can be real heart valve tissue from an animal or, more often, the cusps are made from pericardium tissue from cows, pigs or horses. These cusps are treated to reduce immunogenicity and improve durability. Many tissue processing techniques have been developed for this purpose. In the future, biologically engineered tissue can be used or polymers or other non-biological materials can be used for valve cusps. All of these can be incorporated into the inventions described in this exhibit.
[008] In fact, there are more patients with mitral valve disease than aortic valve disease. Over the past decade, many companies have been successful in creating minimally invasive implantable aortic catheters or valves, but mitral valve implantation is more difficult and, to date, has not been a good solution. Patients would benefit from implantation of a device by a surgical procedure employing a small incision or by a catheter implantation, such as from the groin. From the patient's point of view, the catheter procedure is very attractive. At this time, there is no efficient way to replace the mitral valve with a catheter procedure. Many patients who want a mitral valve replacement are identifiers, and an open heart procedure is painful, risky, and takes time to recover. Some patients are not even candidates for surgery due to their advanced age and frailty. Therefore, there is a particular need for a remotely positioned mitral valve replacement device.
[009] Although it was previously thought that mitral valve replacement rather than valve repair was associated with a more negative long-term prognosis for patients with mitral valve disease, this belief has been questioned. It is now believed that the outcome for patients with mitral valve leakage or regurgitation is almost the same regardless of whether the valve is repaired or replaced. Furthermore, the durability of a surgical mitral valve repair is now in question. Many patients, who undergo repair, develop a leak again over several years. As many of them are elderly, repeated intervention on an elderly patient is not welcomed by the patient or physicians.
[0010] The most prominent obstacle to catheter mitral valve replacement is holding the valve in place. The mitral valve is subject to a large cyclic load. The pressure in the left ventricle is close to zero before a contraction and then rises to systolic pressure (or higher if there is aortic stenosis), and this can be very high if the patient has systolic hypertension. Often the load on the valve is 150 mmHg (20 kPa) or more. Since the heart is moving as it beats, the movement and load can combine to dislodge a valve. Also, movement and rhythmic loading can fatigue a material leading to material fractures. Thus, there is a big problem associated with anchoring a valve.
[0011] Another problem with creating a catheter-shipped mitral valve replacement is size. The implant must have strong retention and leak prevention features, and must contain a valve. A separate prosthesis can contribute to solving this problem by replacing an anchorage or coupling first, and then implanting the valve second. However, in this situation, the patient must remain stable between an anchorage or coupling implantation and valve implantation. If the patient's native mitral valve has been rendered non-functional by anchorage or coupling, then the patient may quickly become unstable, and the operator may be forced to quickly implant the new valve or possibly stabilize the patient by removing the anchorage or coupling and abandoning the procedure.
[0012] Another problem with mitral cross section is a leak around the valve, or a paravalvular leak. If a good seal is not established around the valve, blood may leak back into the left atrium. This puts an extra load on the heart, and can damage the blood as it jets through leak sites. A hemolysis or decomposition of red blood cells is a frequent complication if this occurs. A paravalvular leak was one of the common problems encountered when the aortic valve was first implanted in a catheter. During surgical replacement, a surgeon has a great advantage when replacing the valve, as he or she can see a gap outside the valve suture line and prevent or repair it. With a catheter insertion, this is not possible. Furthermore, large leaks can reduce a patient's survival, and can cause symptoms that restrict mobility and make the patient uncomfortable (eg, shortness of breath, edema, fatigued). Therefore, devices, systems and methods which refer to a mitral valve replacement must also incorporate means to prevent or repair leaks around the replacement valve.
[0013] An annular space of a patient molding machine can also be quite large. When companies develop surgical replacement valves, this problem is solved by restricting the number of sizes of the actual valve produced and then adding more tissue sleeve around the valve margin to increase valve size. For example, a patient may have a 45mm annular valve space. In this case, the actual prosthetic valve diameter may be 30 mm, and the difference is made up by adding a large band of tissue sleeve material around the prosthetic valve. However, in catheter procedures, adding more material to a prosthetic valve is problematic as the material must be condensed and retained by small delivery systems. This method is often very difficult and impractical, so alternative solutions are needed.
[0014] Since numerous valves have been developed for the aortic position, it is desirable to avoid repetitive valve development and take advantage of existing valves. These valves have been very expensive to develop and bring to market; thus, extending your application can save considerable amounts of time and money. It would be helpful, then, to create a docking station or mitral coupling for such a valve. An existing valve developed for the aortic position, perhaps with some modification then, could be implanted in the docking station. Some previously developed valves can fit well without modification, such as the Edwards Sapien™ valve. Others, such as Corevalve™ may be implantable, but require some modification for an optimal fit with anchorage and adaptation within the heart.
[0015] Several other complications can arise from a poorly retained or poorly positioned mitral valve replacement prosthesis. Specifically, a valve can become dislodged in the atrium or ventricle, which could be fatal to a patient. Previous prosthesis anchorages have reduced the risk of dislodgement by perforating tissue to retain the prosthesis. However, this is a risky maneuver as penetration must be performed by a sharp object over a long distance, leading to a risk of heart perforation and patient injury.
[0016] An orientation of the mitral prosthesis is also important. The valve must allow blood to flow easily from the atrium into the ventricle. A prosthesis that enters at an angle can lead to poor flow, obstruction of flow through the heart wall or a cusp, and poor hemodynamic outcome. A repeated contraction against the ventricular wall can also lead to a rupture of the back wall of the heart and the patient's sudden death.
[0017] With surgical mitral valve repair or replacement, sometimes the anterior cusp of the mitral valve cusp is pushed into the left ventricular outflow area, and this leads to poor left ventricular emptying. This syndrome is known as left ventricular tract outflow obstruction. The replacement valve itself can cause a left ventricular tract outflow obstruction if it is located close to the aortic valve.
[0018] Yet another obstacle faced when implanting a replacement mitral valve is the need for the patient's native mitral valve to continue to function regularly, without positioning the prosthesis, so that the patient can remain stable, without the need to a heart-lung machine to support circulation.
[0019] In addition, it is desirable to provide devices and methods that can be used in a variety of implementation approaches. Depending on a particular patient's anatomy and clinical situation, a medical professional may wish to make a determination regarding the optimal method of implantation, such as inserting a replacement valve directly into the heart in an open procedure (open heart surgery or minimally invasive surgery) or the insertion of a replacement valve from veins and via arteries in a closed procedure (such as a catheter-based implantation). It is preferable to allow a medical professional a plurality of implantation options to choose from. For example, a medical professional may wish to insert a replacement valve from the ventricle or from the atrial side of the mitral valve.
[0020] Therefore, the present invention provides devices and methods that address these and other challenges in the art. SUMMARY
[0021] In an illustrative embodiment, a system for coupling a heart valve prosthesis is provided, and includes a helical anchor formed as multiple spirals adapted to support a heart valve prosthesis with spiral portions positioned above and below the annular space of heart valve, and a seal coupled to the helical anchorage. The seal includes portions that extend between adjacent spirals to prevent blood leakage through the helical anchorage and in front of the heart valve prosthesis.
[0022] The system may further include a heart valve prosthesis capable of being sent to a patient's heart valve position and expanded within the multiple spirals and for engagement with heart valve leaflets. The seal is fitted with both the helical anchorage and the heart valve prosthesis. The spirals of the helical anchor may be formed of a superelastic or shape memory material, or other suitable material. The seal can be a membrane or a panel that extends over at least two spirals of the helical anchor. The membrane or panel is moved between an undeployed state and an implanted state, the undeployed state being adapted for shipment to an implantation site and the implanted state being adapted for implanting the system and anchoring the heart valve prosthesis. The undeployed state can be a state wrapped around one of the spirals of the helical anchorage, or any other collapsed state. The membrane or panel may include a support element affixed thereto, such as a spring-guided inner wire. The seal may further include one or more seal elements carried by the helical anchorage and including overlapping portions configured to seal a space between adjacent spirals of the helical anchorage. One or more seal elements each include a support element affixed to them. One or more seal elements can generally be, for example, of circular or oblong cross-sectional shape. The one or more seal elements may each have a connecting portion affixed to one of the spirals and an extension portion extending towards an adjacent spiral, for providing an inter-spiral seal function.
[0023] In another illustrative embodiment, a system for replacing a native heart valve includes an expandable helical anchor formed as multiple spirals adapted to support a heart valve prosthesis. At least one of the spirals is usually defined by a first diameter and is expandable to a larger second diameter by applying an outward radial force from within the helical anchor. The system further includes an expandable heart valve prosthesis capable of being sent in the helical anchorage and expanded within the multiple spirals in engagement with at least one spiral to move at least one spiral from the first diameter to the second diameter while engaging the helical anchorage and the heart valve prosthesis together.
[0024] As a further aspect, the helical anchorage may include another spiral that moves from a larger diameter to a smaller diameter as the heart valve prosthesis is expanded within the multiple spirals. At least two adjacent spirals of the helical anchorage can be spaced apart, and adjacent spirals move toward each other as the heart valve prosthesis is expanded within the multiple spirals. The helical anchorage may further include a plurality of fasteners, and the fasteners are moved from an undeployed state to an deployed state as at least one spiral moves from the first diameter to the larger second diameter. A seal can be attached to the helical anchorage and include portions extending between adjacent spirals to prevent blood leakage through the helical anchorage and in front of the heart valve prosthesis. The system may further include at least one compressible element in the helical anchorage, the compressible element being engaged by the heart valve prosthesis as the heart valve prosthesis is expanded within the multiple spirals to assist with the attachment of the heart valve prosthesis to helical anchorage. The compressible element can take any of a number of forms, such as a fabric or other soft material, or a resilient, elastic material such as a polymer or foam. At least one compressible element can further include multiple compressible elements spaced along the multiple spirals. The heart valve prosthesis may further include an expandable structure including openings. The openings are fitted by at least one compressible element, as the heart valve prosthesis is expanded within the multiple spirals, for purposes of strengthening the connection between the anchorage and the prosthesis. The multiple spirals of the helical anchorage can include at least two spirals that intersect each other. This system can include any system features or features that use the seal and vice versa, depending on the functions and effects desired.
[0025] Methods of implanting a heart valve prosthesis into a patient's heart are also provided. In an illustrative embodiment, the method includes sending a helical anchorage in the form of multiple spirals so that a portion of the helical anchorage is above the native heart valve and a portion is below the native heart valve. The heart valve prosthesis is implanted in the multiple spirals of the helical anchorage so that the heart valve prosthesis is supported by the helical anchorage. A seal is positioned between at least two adjacent spirals of the helical anchorage and the heart valve prosthesis to prevent leakage of blood flow during an operation of the heart valve prosthesis.
[0026] The positioning of the seal may further comprise the positioning of a membrane or a panel that extends over at least two spirals of the helical anchorage. The method further includes sending the membrane or panel in an undeployed state to the native heart valve site and then employing the membrane or panel in the helical anchorage, and expanding the heart valve prosthesis against the membrane or the panel. The undeployed state includes a curled state or a collapsed state. Seal positioning may further include positioning one or more seal elements carried by the helical anchor so that the overlapping portions seal a space between adjacent spirals of the helical anchor. One or more seal elements may each include a support element affixed to them.
[0027] In another embodiment, a method of implanting an expandable heart valve prosthesis to a patient is provided. This method includes sending an expandable helical anchor in the form of multiple spirals so that a portion of the expandable helical anchor is above the native heart valve and a portion is below the native heart valve. The expandable heart valve prosthesis is positioned in the multiple spirals of the expandable helical anchorage with the expandable heart valve prosthesis and the expandable helical anchorage in unexpanded states. The expandable heart valve prosthesis is then expanded against the expandable helical anchor, thereby securing the expandable heart valve prosthesis to the expandable helical anchor. By “expandable” it is meant that at least one anchor spiral increases in diameter.
[0028] The method may further include moving a spiral from a larger diameter to a smaller diameter as the heart valve prosthesis is expanded within the multiple spirals. At least two adjacent spirals of the helical anchorage may be spaced apart, and the method further comprises moving at least two adjacent spirals towards each other as the heart valve prosthesis is expanded within the multiple spirals. The helical anchorage may further comprise a plurality of fasteners, and the method further comprises moving the fasteners from an undeployed state to an implanted state as the expandable heart valve prosthesis is expanded against the expandable helical anchorage. A seal can be positioned between adjacent spirals to prevent blood leakage through the helical anchorage and in front of the heart valve prosthesis, and the fasteners engage the seal in the implanted state. Fasteners, instead, can fit into a portion of the anchor, which is not a seal. Any other aspects of the methods or systems set forth herein may be used, either as well or alternatively, in this method, depending on the desired result.
[0029] Various additional advantages, methods, devices, systems and features will become more readily apparent to those of ordinary skill in the art upon a review of the following detailed description of illustrative embodiments taken in conjunction with the associated drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1A is a schematic cross-sectional view illustrating a replacement heart valve implanted in a native valve position using a helical anchorage.
[0031] Figure 1B is a schematic cross-sectional view similar to Figure 1A, but illustrating the use of seals in conjunction with the helical anchorage.
[0032] Figure 2A is a perspective view illustrating a method of applying the seal structure to the helical anchorage.
[0033] Figure 2B is a perspective view illustrating another step in the method illustrated in Figure 2A.
[0034] Figure 2C is a cross-sectional view showing the helical anchorage after applying the seal.
[0035] Figure 2D is an enlarged cross-sectional view of the helical anchor having a seal shape applied.
[0036] Figure 2E is a cross-sectional view similar to figure 2D, but illustrating an alternative embodiment of the seal.
[0037] Figure 2F is another enlarged cross-sectional view similar to Figure 2E, but illustrating another alternative embodiment for the seal.
[0038] Figure 3A is a schematic perspective view illustrating another alternative embodiment of the helical anchorage and seal.
[0039] Figure 3B is a cross-sectional view of the embodiment shown in Figure 3A, with the adjacent helical spirals compressed for shipping.
[0040] Figure 3C is a cross-sectional view showing the helical anchorage and expanded seal after shipping.
[0041] Figure 3D is a partial perspective view illustrating another illustrative embodiment of the helical anchorage.
[0042] Figure 3E is a schematic elevation view, partially broken away, to show the application of a seal to the helical anchorage structure of Figure 3D.
[0043] Figure 3F is an enlarged cross-sectional view illustrating another embodiment of a helical spiral structure with a seal.
[0044] Figure 3G is a cross-sectional view similar to figure 3F, but illustrating the structure after shipping and unfolding the seal.
[0045] Figure 3H is a cross-sectional view similar to Figure 3G, but illustrating multiple parts of the helical anchor structure and an associated expanded seal after shipping.
[0046] Figure 4A is a perspective view illustrating a helical anchorage in combination with another alternative embodiment of a seal.
[0047] Figure 4B is a perspective view of the seal illustrating an alternative embodiment which adds a support structure to the seal.
[0048] Figure 4C is a schematic cross-sectional view illustrating the embodiment of Figure 4A implanted in a native heart valve position.
[0049] Figure 4D is a schematic cross-sectional view illustrating a replacement heart valve implanted in the helical anchorage and a seal structure of figure 4C.
[0050] Figure 5A is a perspective view of a helical anchor with a membrane seal or panel being applied.
[0051] Figure 5B is a perspective view of the helical anchorage with the membrane seal or panel of Figure 5A deployed or deployed.
[0052] Figure 5C illustrates a perspective view of the membrane seal or panel with an internal support structure.
[0053] Figure 5D is an enlarged cross-sectional view of the helical spiral and an undeployed membrane seal.
[0054] Figure 5E is a cross-sectional view similar to Figure 5D, but illustrating a membrane seal, which has been collapsed or folded, rather than wrapped around a helix spiral.
[0055] Figure 5F is a perspective view of a portion of the spiral and membrane seal illustrating additional details including the internal support structure and a suture line.
[0056] Figure 5G is a cross-sectional view illustrating the helical spiral and membrane seal implanted in a native heart valve site.
[0057] Figure 5H is a cross-sectional view similar to Figure 5G, but still illustrating a replacement or prosthetic heart valve implanted in the helical coil and membrane seal.
[0058] Figure 6A is a cross-sectional view illustrating a helical spiral implanted and at a native heart valve site being expanded by a balloon.
[0059] Figure 6B is a cross-sectional view illustrating a replacement or prosthetic heart valve with a stent implanted in a helical spiral structure and membrane seal.
[0060] Figure 7A is a cross-sectional view schematically illustrating a helical anchor having approximately two turns or spirals having a first diameter and another spiral having a larger second diameter.
[0061] Figure 7B illustrates an initial step during deployment of the helical anchorage shown in Figure 7A at a native heart valve site with a stent-mounted replacement heart valve ready for deployment with the helical anchorage.
[0062] Figure 7C illustrates an additional portion of the procedure in which the stent replacement heart valve is expanded using a balloon catheter.
[0063] Figure 7D is an additional portion of the procedure and illustrates a cross-sectional view of the replacement heart valve implanted in the helical anchorage.
[0064] Figure 7D-1 is a cross-sectional view of a replacement heart valve implanted in a helical anchorage, similar to Figure 7D, but illustrating alternative configurations for the replacement heart valve and anchorage.
[0065] Figure 8A is an elevation view of another embodiment of a helical anchor being expanded by a balloon catheter.
[0066] Figure 8B is a view similar to Figure 8A, but illustrating a further expansion of the balloon catheter.
[0067] Figure 8C is a view similar to Figure 8B, but illustrating further expansion of the balloon catheter.
[0068] Figure 8D is an enlarged cross-sectional view showing a compression of the helical spirals from Figure 8C.
[0069] Figure 9A is an elevation view of another embodiment of a helical anchor being expanded by a balloon catheter.
[0070] Figure 9B is a view similar to Figure 9A, but illustrating a further expansion of the balloon catheter.
[0071] Figure 9C is a view similar to Figure 9B, but illustrating further expansion of the balloon catheter.
[0072] Figure 9D is an enlarged cross-sectional view showing the compression of helical spirals from Figure 9C.
[0073] Figure 10A is a partial cross-sectional view illustrating another embodiment of a helical anchorage inserted or implanted into a native heart valve site and the insertion of a stent-mounted replacement heart valve into the helical anchorage and in place of native heart valve.
[0074] Figure 10B is a cross-sectional view similar to Figure 10A, but illustrating the expansion and implantation of the stent-mounted replacement heart valve in the helical anchorage.
[0075] Figure 10C is a partially broken away cross-sectional view of the implanted replacement heart valve and helical anchorage shown in Figure 10B.
[0076] Figure 10C-1 is an enlarged cross-sectional view showing the fit between the replacement heart valve stent and the helical anchorage.
[0077] Figure 10D is a top view illustrating the expansion process of the stent-mounted replacement heart valve in the helical anchorage of Figure 10C.
[0078] Figure 10E is a top view similar to Figure 10D but illustrating full expansion and stent-mounted replacement heart valve implantation.
[0079] Figure 11A is a partial cross-sectional view illustrating another embodiment of a helical anchorage inserted or implanted into a native heart valve site and insertion of a stent-mounted replacement heart valve into the helical anchorage and a site of native heart valve.
[0080] Figure 11B is a cross-sectional view similar to Figure 11A, but illustrating expansion and implantation of the stent-mounted replacement heart valve in the helical anchorage.
[0081] Figure 11C is a top view illustrating the expansion process of the stent-mounted replacement heart valve in the helical anchorage of Figure 11B.
[0082] Figure 11D is a top view illustrating full expansion of the stent-mounted replacement heart valve in the helical anchorage of Figure 11C.
[0083] Figure 12A is an elevation view of another embodiment of a helical anchorage.
[0084] Figure 12B is a cross-sectional view of another embodiment of a helical anchor.
[0085] Figure 12C is an enlarged cross-sectional view of the helical anchor taken along line 12C-12C of Figure 12B.
[0086] Figure 12D is a top view of a helical anchor illustrating expansion by a balloon catheter.
[0087] Figure 12E is a cross-sectional view of the helical anchor shown in Figure 12D, but expanded to show the employment of the parts in the fabric seal.
[0088] Figure 13A is an elevation view of another embodiment of a helical anchorage.
[0089] Figure 13B is a cross-sectional view of another embodiment of a helical anchor.
[0090] Figure 13C is an enlarged cross-sectional view of the helical anchor taken along line 13C-13C of figure 13B with the use of burrs in the outer seal layer.
[0091] Figure 14A is a perspective view of an alternative helical anchorage.
[0092] Figure 14B is a top perspective view of the helical anchor shown in Figure 14A.
[0093] Figure 14C is a front view of the helical anchor shown in figures 14A and 14B. DETAILED DESCRIPTION OF ILLUSTRATIVE MODALITIES
[0094] It will be appreciated that like reference numerals are used to reference essentially similar structures or features in each of the drawings. Differences between these elements will generally be described as needed, but the same structure need not be described repeatedly for each figure, as an earlier description may be referred to rather than for the sake of clarity and brevity. Figure 1 schematically illustrates a typical replacement heart valve or prosthesis 10 that can be implanted in the position of a native heart valve, such as mitral valve 12, using a catheter (not shown). A sealed condition is desired around the valve 10, i.e. between the periphery of the replacement valve 10 and the native biological tissue, in order to prevent blood leakage around the periphery of the replacement valve 10, as per the cusps 14, 16 of the replacement valve 10 open and close during the systolic and diastolic phases of the heart. The portion of replacement heart valve 10 intended to be positioned in contact with native tissue includes a tissue or polymeric covering 18 to prevent regurgitation of blood flow. In Figure 1A, tissue covering 18 is shown adjacent to the replacement valve cusps 14, 16 in the stent mounted replacement valve 10. These replacement valve cusps 14, 16 typically are formed from a biological material such as like from a cow or a pig, but they can be synthetic or other bioforms. Approximately half of this replacement valve 10 is unsealed, that is, it is a more or less exposed stent 24 with openings 24a. This is because, when the replacement valve 10 is placed in the native aortic position, the coronary arteries ascend just above the aortic valve. If seal 18 extended the entire length of stent portion 24, the coronary artery could be blocked. In Figure 1A, an unmodified aortic replacement valve 10 is shown implanted in a helical anchorage 30 comprised of spirals 32. A blood flow leak can occur, as schematically depicted by arrows 36, because there is a gap between the seal 18 in the valve. with stent 10 and attachment to the patient's mitral valve 12. Blood flow leakage can occur in any direction. Here, arrows 36 describe the leakage that occurs from ventricle 40 to atrium 42, since ventricular pressure is higher than atrial pressure. An unmodified aortic valve 10 placed in the native mitral valve position will be prone to develop a leak. To avoid this problem, two main approaches can be taken. First, a seal can be added to the system, for example the helical anchor 30 can have sealing features added. Second, the location where the stent-mounted replacement heart valve 10 sits can be changed. In this regard, if replacement heart valve 10 is positioned lower within ventricle 40, seal 18 on replacement heart valve 10 could cause damage within left ventricle 40, or valve 10 could obstruct a ventricular contraction. Replacement valve 10 can damage the ventricular wall or block the outflow of blood from ventricle 40 to the aorta. Rather than simply seating the replacement heart valve 10 deeper or lower in the left ventricle 40, it may be helpful to maintain the position of the stent-mounted replacement valve 10 positioned more atrially, as described in Figure 1A (ie. , positioned higher and extending into the atrium 42).
[0095] Figure 1B illustrates an embodiment of providing a seal structure 50 in the upper portion of a replacement heart valve 10 to prevent a blood flow leakage, as discussed above and shown in Figure 1A. In this regard, one or more seals 52 have been added to the helical anchor 30. Specifically, a fabric covered oval seal structure 52 is added to the helical anchor 30 for the provision of a seal. Seal 52 can be formed from a tissue, or any other material that provides a sufficient seal and does not allow blood to flow therethrough. Seal 52 extends down to the level of the attachment between the stent-mounted replacement valve 10 and the native mitral cusps 12a, 12b. The seal 52, in this illustrative embodiment, is a continuous tube and comprises one or more seal elements or portions 52a, 52b, 52c in the form of overlapping segments of fabric or other sealing material. These sealing structure segments 52a, 52b, 52c act as a siding structure or tiles for sealing the space between the spirals 32 or turns of the helical anchorage 30.
[0096] Figure 2A illustrates a way of applying the overlapping seal structure 50, as shown in Figure 1B, or otherwise integrating the seal structure 50 into the helical anchorage 30. In this sense, the seal structure 50 can be integrated with the 30 helical anchor for shipping purposes. The tiles or overlay seal portions 52a-c (figure 1B) can be collapsed and extruded from a catheter 60. Alternatively, once the helical anchorage 30 has been sent to the native heart valve site, tissue or another seal structure 50 can be sent over the spirals 32 of the anchorage 30 from the same shipping catheter 60. Alternatively, the overlapping seal structure 50 can be added to the helical anchorage 30, as the helical anchorage 30 is being extruded or extending from delivery catheter 60. Figure 2A specifically illustrates a helical anchor 30 with a fabric or other seal structure 50 being fed over helical spirals 32 from a sheath or delivery catheter 60. The seal structure 50 may be generally circular in cross-section or of any other shape, such as a shape that is better configured for superposition, as shown generally in Figure 1B above. Figure 2B illustrates a fabric 62 and an inner support spiral 64 being added to the helical anchorage 30 in an additional portion or step of the procedure illustrated in Figure 2A. Figure 2C illustrates an embodiment of a completed assembly, shown in cross-section, comprising the helical anchor 30 covered by coil 64 and fabric 62 and delivered by a sheath or delivery catheter 60. The sheath or delivery catheter 60 may remain over the spiral and fabric combination, or can be used merely for sending these sealing elements 62, 64 by the helical anchorage 30.
[0097] Figure 2D illustrates a cross-sectional view of the sealing elements 62, 64, which, in this case, are circular in cross-section. These sealing elements 62, 64, including, for example, a combination of spiral support and fabric, can be of virtually any shape, as long as they provide a seal when positioned together. The sealing elements 62, 64 may not overlap in use, but rather contact each other as shown to create a seal between them.
[0098] Figure 2E shows a seal structure with an oblong or oval cross-sectional shape 70 similar to the seal 50 shown in Figure 1B, in which segments 70a, 70b overlap each other, to produce a secure seal and fluid tight. It is possible to have the oblong seal structure 70 compressed for shipping and then spring-opened or guided once the seal structure 70 is extruded from a shipping catheter or sheath. A spiral 74 internally supporting the fabric 72 can be made of Nitinol yarn (superelastic) or a spring steel wire so that it can be collapsed and then oriented or spring-backed to a predetermined shape, as per required.
[0099] Figure 2F shows another alternative seal structure 80. In this case, a sealing fabric 82 or other material is wrapped around the helical anchor 30. The fabric is stitch sewn together with a suitable line for forming of rigid structural panels 84 extending from the connecting portion 86 which is affixed to a spiral 32 of the helical anchorage 30. The panels 84 again overlap, similarly to a tile effect, for the provision of a watertight seal to fluid. This configuration can be shipped in a manner similar to the fabric-covered spiral designs previously described above by passing the panel structure over the helical anchor 30, as shown.
[00100] Figure 3A illustrates another embodiment for the provision of a sealing structure. In order to provide additional shape and support for a seal structure 90, there may be two or more "framing" segments 92, 94 within a fabric covering 96 or other material seal. This will provide a shape for the seal structure 90 and provide a more reliable superposition of the seal segments (only one shown in Figure 3A). This can be achieved by using a double helix, in which two wires 92, 94 run parallel to each other to form a helical shape. The two wires 92, 94 can be connected at their ends with a curved section 98, as shown in figure 3A. The fabric or other material or liner sleeve 96 may be passed over the double helix during or after shipping this helical seal structure 90.
[00101] Figure 3B illustrates a cross-sectional view of the seal structure 90 compressed with threads 92, 94 within the outer fabric or other material 96. This may provide easier shipping to the deployment side.
[00102] Figure 3C illustrates the double helix seal 90 spread out and overlapping after shipping. Two segments 90a, 90b of the helical seal 90 may expand as they are being sent to form the overlapping seal segments 90a, 90b, similar to the “tile” configuration discussed above. Here, two overlapping seal segments 90a, 90b are supported by two double helix frames 92, 94 positioned adjacent and overlapping each other to produce an effective fluid tight seal.
[00103] Figure 3D illustrates another alternative method for coupling frame segments 92, 94 of a stamp and specifically orienting frame segments 92, 94 apart. Interconnecting segments 100 between the two frame parts or wires 92, 94 can push frame segments 92, 94 into a final desired shape. This double helix design can be made from multiple pieces of wire or can be made from a single tube or wire of Nitinol or solid steel, similar to stent fabrication techniques. The seal frame 92, 94 may also have a sinusoidal or generally back and forth configuration (not shown), to maintain a tile-like shape, rather than two rails or wires within the outer seal material or fabric. 96 (figure 3C).
[00104] Figure 3E details how the outer seal material or fabric 96 can be placed over the expanded frame 92, 94. The seal material 96 can be pre-attached to the double helix frame 92, 94 and both can be shipped together. Alternatively, the seal material 96 can be shipped in the double helix frame 92, 94 after the double helix frame 92, 94 is already in place at the implantation site, such as the site of a native mitral valve. In the unexpanded state, the double helix 92, 94 can be extruded through a catheter, as previously described.
[00105] Figures 3F, 3G and 3H generally show the progression of shipping and deploying seal 90. In these figures, seal material or fabric 96 extends beyond frame 92, 94 to form tabs or panels 102 of material of stamp. These flaps or panels 102 can be stiffened and reinforced with a heavy suture, or the material can be soaked or coated in a stiffening agent. This can be useful to ensure a fluid tight seal. In Figure 3F, the inner wire frame 92, 94 is collapsed and the fabric cover 96, 102 is folded into a shipping hem 60 for shipping. In Figure 3G, frame 92, 94 has been sent and the segments or flaps 102 of stamp material 96 that extend beyond frame 92, 94 have unfolded. Figure 3H illustrates frame portions 92, 94 expanded in a similar manner to a stent. This provides a solid and secure seal. Cross members or guide members 100 that were collapsed inside the double helix frame 92, 94 are now guided outward and extended or straightened. These cross members 100 can be made of Nitinol or other spring material and expand frame 92, 94 with a spring force as frame 92, 94 is shipped from a catheter or sheath 60. Alternatively, there may be another mechanism or manner for activating and expanding frame 92, 94 as needed during the implant procedure.
[00106] Figure 4A illustrates another embodiment for adding sealing features to a helical anchor 30. Here, a fabric windsock type shape or panel/membrane structure 110 has been mounted on an upper loop or spiral 32 of the helical anchor 30. This panel 110 unfolds or extends into helical anchorage 30 for the provision of a sealing membrane. The fabric or other seal material can be sewn or permanently attached to the helical anchorage 30. Alternatively, this panel 110 can be sent to the helical anchorage 30, after the helical anchorage 30 is placed into the implant site in a native heart valve. The seal material 110 can be affixed to any portion of the helical anchorage 30 at any level of the anchorage 30. In Figure 4A, the seal panel 110 is affixed to the uppermost spiral 32 of the helical anchorage 30, so that the panel 110 is then can expand to the full length of the helical anchor 30 and provide a full length fluid-tight seal.
[00107] Figure 4B illustrates the open seal panel 110 and an internal support structure 112, in the form of a wire or a sine-type support element within or within layers of the seal material. This support structure 112 for the seal 110 can be made, for example, of Nitinol or steel. Holder 112 may be sewn into the fabric or otherwise secured to the seal material. The fabric could contain, for example, a channel for the support 112, and the support 112 could be pushed into the channel, expanding the seal material 110 as needed. If holder 112 is made of Nitinol or a superelastic material, and embedded within the fabric or seal material 110, it may straighten and fold the fabric or other seal material into a delivery catheter or sheath. While being shipped, the Nitinol or superelastic support would return to its initial zigzag or sinusoidal shape, expanding the tissue as it was released and extruded from the shipping sheath or catheter.
[00108] Figure 4C is a cross-sectional view illustrating a helical anchor 30 and tissue seal panel 110, as shown in figure 4A, shipped and deployed in a native valve location, screen as in mitral valve 12 of a patient. Seal panel 110 is stitch-sewn into the upper loop or spiral 32 of helical anchorage 30, and the fabric folded back on itself and sewn together as shown. Stitch sewing 114 can also provide structural support to help shape the fabric itself correctly. Stitch sewing can be made of a steel wire or a Nitinol wire which can aid in providing shape stability to the membrane or panel structure 10. Stitch stitching 114 can also be a suture or thread. The heavier the stitch sewing material, the more support it will provide for the fabric. Here, stitch sewing is in horizontal lines; however, it can have other settings instead, such as vertical, zigzag or any other suitable setting.
[00109] Figure 4D illustrates a stent mounted heart valve 10 expanded into the helical anchorage 30 and the seal structure 110 of Figure 4C. Seal 110 prevents any blood leakage around valve 10, and covers any areas of stent portion 24 of replacement valve 10 that are not already covered and sealed. The seal 110 allows the replacement heart valve 10 to be seated higher towards the atrium 42, thereby reducing the risk of damage to the left ventricle or an obstruction to the outflow of blood from the ventricle.
[00110] Figure 5A illustrates a helical anchor 30 with an affixed membrane or panel seal 110 being sent to the spirals 32 of the helical anchor 30. It should also be noted that the membrane or panel seal 110 can also improve affixation of the replacement heart valve 10. In this regard, a bare helical anchor 30, particularly one made of metal, that attaches to a metal stent will result in metal surfaces contacting each other. As the heart beats and pressure rises with each contraction, for example, around 100,000 times a day, there is a risk of slipping between metal surfaces and potential valve dislodgement. Therefore, the addition of a membrane, panel 110 or other seal structure can reduce the tendency for valves to slip and even fail. Membrane panel or seal 110 can be smooth or have varying degrees of texture or roughness to help maintain attachment of the replacement heart valve 10. Textured or rough surfaces will increase friction and therefore reduce slippage. Also, tissue or other seal material 110 can be forced into the openings or cells of the stent portion 24 and anchoring the stent-mounted replacement valve 10 to the helical anchorage 30 including the seal material 110. In Figure 5A, membrane or panel seal 110 is affixed to helical anchorage 30 and, as previously described, membrane or panel seal 110 can be affixed prior to implantation into the patient or added at any point during the implantation procedure. It may be additionally advantageous for the membrane seal or panel 110 after the helical anchorage 30 is placed in the implantation site, so as to reduce a complication during shipping of the helical anchorage 30. Figure 5B illustrates the membrane seal or the implant seal. panel 110 unfolded or expanded in helical anchorage 30. As previously described, membrane seal or panel 110 is affixed to the uppermost loop 32 of helical anchorage 30, although it can be affixed anywhere along helical anchorage 30. membrane or panel 110 may be continuous or intermittent, and may be comprised of overlapping panel portions similar to a tile effect. Although the membrane or panel seal 110 creates a complete annular space, as shown in Figure 5B in the helical anchorage 30, it can be formed smaller than a complete annular space instead.
[00111] Figure 5C is similar to Figure 4B described above and simply illustrates that, in this embodiment, the shipped and deployed membrane seal 110 may also include a similar internal support 116. It is also possible that the membrane seal or panel 110 is intrinsically rigid and moves in an open spring, without an internal support structure of any kind. Many other ways to open or employ the membrane seal or panel 110 can be used instead. For example, panel seal 110 may contain posts or other supports (not shown) that are collapsed for shipping, but which allow the membrane or panel 110 to be oriented open once the membrane or panel 110 is shipped to from a suitable catheter or sheath. These pillars or other supports can be formed, for example, from a shape memory or superelastic material, or other suitable spring-driven material.
[00112] Figure 5D illustrates the panel seal 110 uncoiling or being deployed. The panel seal 110, in this illustrative embodiment, is formed of two layers with a backing 116 between these two layers. Support 116, as described above, is suitably secured between the layers of panel seal 110. Although shown as a sinusoidal configuration, support 116 can be of any desired and suitable configuration, or can be comprised of separate support structures. , such as generally circular or oval support structures (not shown). Other structures useful in this regard may include any of those described in U.S. Provisional Patent Application Serial No. 61/864,860, filed August 12, 2013, the disclosure of which is thereby fully incorporated by reference herein. Finally, strands (not shown) may be added to the end of the membrane seal 110 or to any part or any parts of the membrane seal 110 that can be used to pull the membrane seal open and unfold or employ it from other way.
[00113] Figure 5E illustrates a membrane or panel seal 110, which has been collapsed or folded back on itself, rather than wrapped around the spiral 32 of the helical anchorage 30. A collapsed membrane seal 110, such as this one, can be more practical. The membrane seal or panel 110 can be opened with the support structure 116 normally oriented to an implanted state, as shown previously, or it can be implanted by containing structural support elements 116, such as shape memory support elements. Also as discussed previously, strands (not shown) could be added for employment purposes.
[00114] Figure 5F illustrates an enlarged cross-sectional view of the helical anchorage 30 with the membrane seal 110 or panel extending adjacent to the spirals 32 of the helical anchorage 30. The panel seal 110 includes a suture line 118 that holds seal 110 in place on helical anchor 30, shown as a dashed line. This need not be a suture, rather the fixation can be provided by any suitable fasteners, glue or other elements that hold the membrane seal or panel 110 in place. In addition, panel seal 110 can be glued or affixed to helical anchorage 30, and this would eliminate the need for separate sutures or fasteners. As previously described, panel seal 110 can be fabric or any other suitable biocompatible material. For example, the seal material in this and any other embodiment can be Dacron or Goretex, or it can be biological material from an animal or human. Other examples of seal material include engineering biomaterials or any combination of biological and/or synthetic materials. Panel seal 110, in this embodiment, is opened with a spring-guided support wire 116, as generally described above, but may be opened in any suitable manner during or after employment and deployment of helical anchorage 30.
[00115] Figure 5G illustrates the combination of helical anchorage 30 and panel seal 110 implanted at the site of a patient's native mitral valve 12 . Figure 5H illustrates a replacement heart valve 10 and, specifically, a stent-mounted replacement heart valve 10 secured in the combination helical anchorage 30 and panel seal 110. These figures are described above with respect to figures 4C and 4D. Thus, it will be appreciated that panel seal structure 110 and helical anchorage 30, regardless of deployment and shipping techniques, provide a fluid-tight seal, as previously described. It will be appreciated that additional features can be used to aid employment of the 110 open panel and membrane seal as shown in figures 5G and 5H. A layer of foam (not shown) can also be positioned in any desired location, for example, to aid in valve sealing and/or retention. The membrane or panel seal 110 can extend the full length of the helical anchor 30 or only a portion of the length. In these figures, Figure 5G illustrates the membrane or panel 110 extending only part of the length, while Figure 5H illustrates the panel or membrane 110 extending almost the entire length of the valve 10. As shown in Figure 5H, the valve Replacement heart valve 10 is positioned in native mitral valve 12 such that much of replacement heart valve 10 rests in the atrium. It will be appreciated that the replacement heart valve 10 may be positioned anywhere along the helical anchorage 30. The helical anchorage 30 may contain the entire replacement or prosthetic heart valve 10 or the replacement heart valve 10 may protrude at either end from the helical anchor 30 or from both ends of the helical anchor 30. The number of spirals or turns 32 of the helical anchor 30 can also be varied. The switch arrangement is to prevent as much leakage as possible, and to keep the replacement heart valve 10 firmly in position after an implant.
[00116] In Figure 5H, a spiral 32 of anchorage 30 extends beyond the prosthetic valve with stent 10 into left ventricle 40. This can serve several functions. The end of the valve with stent 10 is sharp and can damage structures within the left ventricle 40. By leaving a turn 32 of the anchorage 30 beyond the end of the valve 10, it may be possible to protect structures within the heart from contacting the sharp end of the valve 10. The lower turn 32 of anchorage 30 can act as a “bumper” that is smooth and prevents damage to structures within the ventricle 40. A smooth metallic helical spiral (such as Nitinol) 32 can be very well tolerated and avoided wear and tear within the left ventricle 40.
[00117] The lower turn or spiral 32 of anchorage 30 can also wrap a native mitral valve cusp tissue around the end of valve 10. This can also shield the sharp end of prosthetic valve 10 from structures within the heart.
[00118] The lower turn or spiral 32 of the helical anchor 30 can also provide traction on rope structures. The function of the left ventricle 40 is improved, and the shape of the left ventricle 40 can be optimized by placing traction on rope structures. In Figure 5H, the lower spiral 32 pulls the chords towards the center of the ventricle 40 and shapes the left ventricle 40 optimally for contraction. It may be useful to have multiple spirals 32 of anchorage 30 extending into left ventricle 40 beyond anchorage 30. These spirals 32 could pull the chords inward for a longer distance into the heart. For example, if a patient had a very large left ventricle 40, it may be desirable to improve this left ventricle function by having a helical extension well beyond valve 10. This would tighten the cords and reshape the left ventricle 40. The spirals 32 of anchorage 30 would also be heavier / thicker in diameter to aid in reconfiguration of the heart. The diameter of spirals 32 could also be varied to optimize left ventricular shape change.
[00119] The concept of left ventricular reconfiguration 40 with anchorage 30 need not apply only to a mitral valve replacement. The helical anchorages 30 shown in these descriptions can also be used for mitral valve repair. Extensions of helical spirals 32 within left ventricle 40 can also reshape left ventricle 40, even when a replacement prosthetic valve 10 is not used. As previously described, various numbers of spirals 32, diameter of spirals 32, thickness of materials, etc. could be used to obtain an optimal result.
[00120] It is also useful to use helical anchorage 30 to repair a native heart valve 12 and reshape the left ventricle 40 and leave open the possibility of adding a replacement prosthetic valve 10 later if repair fails over time. After a surgical valve repair, this is not uncommon. An anchorage 30 that serves as a repair device with or without a left ventricular reconfiguration with spirals 32 that extend into the left ventricle 40 may be useful as an anchorage 30, if a prosthetic valve replacement is needed later.
[00121] Figure 6A illustrates a helical anchorage 30 implanted in the native mitral valve position. In general, it will be important to seat the helical anchorage 30 close to the lower surface of the native mitral valve 12. If the diameter of the spirals 32 or loops under the mitral valve 12 is 30, the heart starts to beat, the helical anchorage 30 is settling into the ventricle left 40 and when there is mitral valve tissue between the helical anchorage 30 and the mitral valve annular space 12c, the helical anchorage 30 will not be firmly affixed to the annular region of the mitral valve 12, but rather to the cusps 12a , 12b lower in the left ventricle 40, and this is not desirable. In Figure 6A, a relatively large diameter turn or spiral 32 of the helical anchorage 30 is positioned immediately under the mitral valve cusps 12a, 12b. This position is directly adjacent to the native mitral valve annular space 12c. The relatively smaller diameter spirals 32 are positioned lower in the left ventricle 40. It may be useful to have a clearance 120 between the relatively larger spiral 32 which is positioned under the valve cusps 12a, 12b in the valve annular space 12c and the relatively larger spiral. smaller 32 positioned farther into the left ventricle 40. This will prevent the entire helical anchorage 30 from being pulled down farther into the left ventricle 40 after an implantation. Relatively smaller diameter spirals 32 of helical anchorage 30 are positioned above mitral valve 12, ie, above the native cusps of mitral valve 12a, 12b. For illustrative purposes, a balloon 122 is shown for purposes of expanding the smaller diameter spirals 32. This causes the larger diameter spiral portions 32 to move relatively inwardly in a radial direction, thereby squeezing all of the spirals 32 together. long of a more similar diameter and tightening the connection between the helical anchorage 30 and the native mitral valve tissue. More importantly, the coil or loop 32 under the native mitral valve cusps 12a, 12b tends to clamp against the underside of the mitral annular space 12c and pull the annular space radially inward, reducing the diameter of the native mitral annular space 12c. An annular reduction in this way is important for the improvement of left ventricular function when the heart is enlarged. An annular diameter reduction of a native mitral valve 12 is also important during mitral valve repair. The smaller diameter annular space adds to the improvement in left ventricular function. The concept of annular reduction using a sliding helical anchorage 30 to control the cusps 12a, 12b and pulling the mitral valve cusps 12a, 12b and annular space 12c radially inward is specifically useful in mitral valve repair. Concepts, methods and devices for improving left ventricular function in a prosthetic mitral valve replacement, that is, replacements that reduce the diameter of annular space and traction cords and reshape the left ventricle 40, will be invoked here demonstrating mitral repair, concepts and methods. A smooth loop or spiral 32 of helical anchorage 30 under the native mitral annular space 12 will have less tendency to bind against the mitral valve tissue and reduce the mitral valve annular space diameter. It may be useful to increase the “hold” of the loop or spiral 32 under the annular space 12c for this reason. This can be accomplished in many ways, including by increasing the surface roughness of the spiral 32, such as by texturing the metal or by adding a high friction coating or fabric. The liner, fabric, or other high friction material can be attached to the helical anchor 30 or can slide along the helical anchor 30. The high friction portion of the helical anchor 30 can be continuous or discontinuous.
[00122] Figure 6B illustrates the final position of the prosthetic replacement heart valve 10 within the helical anchorage 30 and its relationship to the native mitral valve 12 and the left ventricular structures. Left ventricular chords 130 were tractioned and, therefore, left ventricle 40 was appropriately reconfigured. The sharp end 132 of the replacement prosthetic heart valve 10 has been covered by a seal material 134, the native valve tissue 136 and a "bumper" 138 of a lower turn or spiral 32 of the helical anchorage 30. This provides multiples. types of protection against injury within the left ventricle 40, due to the sharp end of the prosthetic valve with stent 10. Also note that the prosthetic heart valve with stent 10 is positioned higher towards the atrium 42, and away from the structure in the left ventricle 40. This provides additional protection from damage to the left ventricle 40 by the replacement heart valve 10. The tissue membrane seal or other type of panel seal 110 can extend to any length. In this situation, it extends beyond the replacement heart valve 10. The tissue or other seal material may also extend beyond the end of the helical anchorage 30 into the left ventricle 40. The tissue or other seal material 110 must cover the end of the replacement heart valve 10, until there is a seal at the level of mitral valve 12. There is also no need for a seal if replacement prosthetic valve 10 has a seal affixed or a seal is otherwise affixed to replacement prosthetic valve 10 In this case, the useful features exposed mainly concern the affixing of the replacement valve 10 to the helical anchorage 30 and the ability of the helical anchorage 30 to reshape the left ventricle 40.
[00123] Figures 7A through 7D illustrate devices, methods, and procedures relating to the interaction of the helical anchorage 30, the helical anchorage design features, and the stent-mounted replacement heart valve 10 shipped or balloon-mounted 140. Multiple catheters can be manipulated to take advantage of a 30 helical anchorage design for improved valve implantation. For example, the stent-mounted replacement valve 10 can be partially employed and the helical anchorage 30 manipulated with the stent-mounted replacement valve 10 in a partially deployed state before the final employment position is reached. Figure 6A illustrates the helical anchorage 30 with three spirals or turns 32. The two top spirals 32 have a relatively smaller dimension d2, while the lower turn or spiral 32 has a relatively larger dimension or diameter d1. Figure 7B illustrates a stent-mounted replacement valve 10 with a balloon 140 in it for employment of the valve 10, once the valve 10 has been positioned within the helical anchorage 30. The helical anchorage 30 is provided with two of the coils or turns 32 positioned below the native mitral valve cusps 12a, 12b and adjacent to the native annular mitral valve space 12c. Arrows 142 indicate the radially outward direction of balloon inflation and resulting expansion of the stent-mounted replacement heart valve 10.
[00124] Figure 7C illustrates an expansion of balloon 140 and stent-mounted replacement heart valve 10. Since the diameter of the two upper spirals or turns 32 of helical anchorage 30 are smaller as balloon 140 is expanded, the Stent-mounted replacement heart valve 10 first contacts the smaller 32 turns of helical anchorage 30. The stent-mounted heart valve 10 becomes fitted against these two smaller diameter turns or spirals 32. While in this position, the catheter employing balloon 140 can be used for manipulation or replacement of the helical anchorage 30. Movement of the balloon catheter 140, such as in the direction of the large arrow 146, will result in the large turn 32 of the helical anchorage 30 being moved upward toward the native mitral annular space 12c in this illustrative example. That is, the loop or spiral portion 32 adjacent to the native mitral annular space 12c will move in the direction of the small arrows 148 adjacent to them. This will also result in an upward movement of the turns or spiral portions 32 above the native mitral valve annular space 12c. In fact, with sufficient force, once the turn or spiral portion 32 below the annular space 12c contacts the cusp 12a or 12b or tissue of annular space 12c below the mitral valve 12, the helical anchorage 30 may actually be open like a spring, so that a segment of helical anchorage 30 connecting the turn or spiral portion 32 above cusp 12a or 12b and below cusp 12a or 12b becomes extended. This can increase the clearance between the segments of the helical anchor 30.
[00125] Figure 7D illustrates a fully expanded stent-mounted replacement heart valve 10, after employment and expansion by a balloon catheter 140, which has been removed. The major turn or spiral 32 of the helical anchorage 30 is positioned relatively high immediately under the native mitral annular space 12c. After a complete inflation of the balloon catheter 140, the system cannot move because the native mitral valve cusps 12a, 12b are now trapped between the helical anchorage 30 and the stent-mounted replacement heart valve 10. The balloon catheter 140 that holds the replacement heart valve 10 can be moved in any direction. In this figure, up and down movements are clearly possible, as these would be made by moving the balloon catheter 140 to and out of the patient. There are also many deflectable catheters, which would allow balloon catheter 140 to move laterally as well.
[00126] This series of figures is intended to show how procedures can be conducted with a helical anchor 30. The anchor 30 can be fitted and manipulated by the valve mounted with stent 10, prior to final positioning and full expansion of the valve with stent 10.
[00127] It is also possible to manipulate the anchor 30 before releasing it. Anchorage 30 may have a catheter or other element affixed to it during this procedure. Thus, both the anchorage 30 and the stent-mounted valve 10 could be remotely manipulated to obtain a desired result.
[00128] Figures 7A to 7D also show how inflating the balloon 140 within smaller loops 32 of the anchorage 30 can serve to "squeeze" a larger loop 32. A portion of the larger loop or spiral 32 under the annular space 12c is stretched above of the annular space 12c, when the minor loop or spiral 32 is expanded, thereby shortening the spiral 32 under the annular space 12c. This allows the large coil 32 to tighten around the valve with stent 10. This effect is most pronounced when a larger coil 32 is located between two smaller coils 32 of the anchor 30. The two small coils 32 on each side of the larger coil 32 expand and thus decrease the diameter of the Larger Coil 32 so that the Larger Coil 32 can trap and aid in the anchoring of the valve 10.
[00129] It is very important to position the anchor 30 as close as possible to the annular space 12c. This is the natural anatomical location for valve 10. If helical anchorage 30 is attached to cusp tissue 12a, 12b remote from annular space 12, cusp tissue 12a, 12b will move with each beat of the heart. This can cause the anchor 30 and valve 10 to rock. Repeated movement can lead to valve dislodgement. Thus, strategies for allowing a placement of large spirals 32 of anchorage 30 near annular space 12c are important. It is also useful to convert a 32 major coil into a 32 minor coil so that the 32 coil can actually work for valve lock with stent 10.
[00130] Figure 7D-1 illustrates another embodiment of a combination of replacement valve 10 and helical anchorage 30, in which the upper end of replacement valve 10 does not taper out, but instead is retained in a relatively cylindrical shape, for example, by upper spirals 32 of the anchorage 30. The lower end or outflow end is tapered radially outwardly as shown. It will be appreciated that a structure, such as a seal (not shown), may be included between the stent 24 and the lower coils 32 for sealing purposes, as described previously, as well as or alternatively to provide a softer, more surface. malleable against native mitral cusps 12a, 12b. In addition, it will be appreciated that the upper spirals 32 create a space and do not fit or trap tissue adjacent to the native mitral valve in the atrium. On the other hand, the mandibular spirals 32 fit into the tissue just below the native mitral annular space 12c. The replacement valve embodiment 10 shown in Figure 7D-1 is in contrast to valves 10 configured as shown previously, such as in Figures 1A and 1B, in which the valve retains a cylindrical shape after an implementation and application of a helical anchor 30, and, for example, that shown in Figure 7D in which the replacement valve 10 includes a very slightly outward-facing configuration at the lower or outflow end, but does not result in any significant taper.
[00131] Figures 8A to 8D illustrate the use of a balloon catheter 140 for expanding a helical anchorage 30 without the presence of a stent-mounted replacement heart valve 10. Specifically, Figure 8A illustrates a helical anchorage 30 with approximately four spirals or turns 32. There are two spirals 32 on each side of a join segment 32a, which separate them to create a gap. The native program cusps (not shown) could easily be positioned between the spirals 32 at the position of the gap created by the seam segment 32a. In this figure, the balloon 140 is beginning to expand, as shown by the radially outwardly directed arrows 150. Figure 8B illustrates further expansion of the balloon 140, thereby causing the helical anchorage 30 to create a recess in the balloon 140 at around the helical anchor 30. The balloon 140 on both sides of the helical anchor 30 expands further. This results in a force on the turns or spirals 32 of the helical anchorage 30 moving them together generally as shown by arrows 152. As the balloon 140 is expanded further, as shown in Figure 8C, the clearance between the turns or spirals 32, 32a decreases and eventually can be completely closed, so that the two main portions of the helical anchorage 30 are compressed against each other in the direction of blood flow or central geometric axis of the helical anchorage 30 (i.e., along the length of the balloon 140). Figure 8D illustrates a cross-sectional view showing the turns or spirals 32, 32a of the helical anchorage 30 compressed together. As shown in these figures, the spirals 32, 32a of the helical anchorage 30 can be compressed against each other by inflating a balloon 140 within the helical anchorage 30. There is no need for a joint segment 32a or a gap for this to occur. The helical spirals 32 would be pressed tightly against each other, with or without the slack illustrated in this embodiment.
[00132] This compression can serve as an "engine" to allow various functions to occur. For example, it may be possible to mount pins or fasteners (not shown) in turns 32, 32a of anchorage 30 that can be actuated and activated by inflation of balloon 140. The pins or fasteners could be positioned so that they pass through the valve cusp native. Fasteners could also traverse native cusps and move to anchorage 30 on the opposite side of the cusp. A fabric coating, sponge coating, or other receptive material on anchorage 30 would improve fastener retention.
[00133] Generally, these methods and devices would allow areas of the mitral valve 12 near the annular space 12c or the annular space 12c to be secured in a helical anchor 30. The fasteners could traverse valve tissue and engage in spirals 32 in a or both sides of the cusps. A cusp entrapment by balloon inflation can allow the mitral valve 12 and its annular space 12 to be manipulated and perform therapeutic procedures. For example, the anchoring spirals 32, once attached to a valve cusp 12a, 12b, could be reduced in size to create a purse string effect in the valve annular space 12c - resulting in an annular reduction procedure or annuloplasty. A lanyard (not shown) could be added to the anchor 30 for diameter reduction.
[00134] Fasteners could be used for joining segments of the helical anchor 30 together. For example, the anchor turns or spirals 32 above the cusp 12a, 12b could be joined together. A fabric or other material could be wrapped around or otherwise positioned in the anchoring spirals 32 and pins or fasteners from one spiral 32 could engage and lock themselves into the fabric from an adjacent spiral 32. The adjacent spirals 32 could fit into each other. This can create a larger mass on each side of the cusp 12a, 12b to control the mitral annular space 12c. In summary, a balloon inflation within a helical anchorage 30 can drive the spirals 32 of the anchorage 30 together. This maneuver can be used as a motor or drive mechanism for activating mechanical systems. You can also move the anchoring spirals 32 tightly together.
[00135] Figures 9A to 9D illustrate another capacity of the helical spiral 30, as the helical anchorage 30 is expanded by a balloon 140. In this sense, the actual total length of the helical spirals 32 forming the anchorage 30 remains the same. Therefore, to increase the diameter of the helical anchor 30, the ends 30a, 30b of the helical anchor 30 must move to accommodate the expansion. This movement can also be used as a motor or drive mechanism to activate additional functions. More specifically, Figure 9A illustrates a balloon 140 being expanded within the helical anchorage 30. As the balloon 140 expands, the diameter of the helical anchorage 30 increases, and the opposite ends 30a, 30b of the helical spiral move to accommodate the expansion . As shown by arrows 160, ends 30a, 30b of spirals 32 move or rotate in opposite directions. Figure 9B illustrates a continuation of balloon expansion and previous figures 8A to 8D show how balloon 140 also compresses the spirals 32 of the helical anchorage 30 together. Figure 9B illustrates how the spirals 32 of the helical anchorage 30 generally rotate as the balloon 140 expands. This rotation is useful in retaining a stent-mounted replacement heart valve as traction around the stent portion of the heart valve (not shown) increases. Figure 9C illustrates that the helical anchor 30 has been unwound as it expands under the force of the balloon 140. There are fewer turns or spirals 32 and the remaining helical turns or anchors 32 are now larger in diameter. The movement of the ends 30a, 30b of the helical anchor 30 can be used to perform functions. As further described below, for example, the movement of the spirals 32 of the helical anchorage 30 can be used to drive anchors or perform other functions.
[00136] Figures 10A to 10E illustrate the effect of a cover or liner 170 on the helical anchorage 30. Also, the replacement valve 10, as shown, for example, in figures 10B and 10C, assumes an outward taper in both the top and bottom ends. This may be desirable for various reasons, but instead at least one end of the replacement valve 10 may be desired to have and retain a generally cylindrical cross-sectional shape (as viewed from above or below). Coating or covering 170 can be in the form of any type of sheath or material applied to helical anchorage 30, and can be comprised of any biocompatible material. For example, liner 170 can be made from a fabric material such as Dacron, Teflon or other material. It can be formed from PTFE or EPTFE in the form of fabric that has a fabric texture or a plastic sleeve, or a cover or coating that is smooth. There may be a foam material under the liner 170, as is commonly used, for example, in surgical valves. The foam material can consist of fabric rolls or fabric plies. Other possible materials include resilient materials or, more specifically, a material such as a medical grade silicone. Biological materials can also be used, and can include animal, human or bioengineered materials. Some materials commonly used in cardiac repair procedures are pericardial wall and intestinal wall materials. Figure 10A illustrates a helical anchor 30 which is covered by a liner 170 comprised of a fabric with a foam material on the fabric back. The helical anchorage 30 is positioned within the native mitral heart valve 12 with two loops or spirals 32 above and two loops or spirals 32 below the native mitral valve annular space 12c. A stent-mounted replacement heart valve 10 is placed within the helical anchorage 30 and an inflation of the balloon delivery catheter 140 into the replacement heart valve 10 has commenced, as indicated by arrows 172. In Figure 10B, the assembled replacement valve with stent 10 is shown fully expanded against helical anchorage 30. Typically, stent portion 24 of valve 10 is comprised of a thin metal material that includes openings or cells. These openings or cells become flush against the sheath or cap 170. The stent 24 therefore fits tightly with the helical anchorage 30, creating a very strong attachment for the replacement valve 10 within the helical anchorage 30. The figure 10C more specifically illustrates an enlarged view demonstrating how the stent portion 24 has deformed the tissue and foam liner 170 of the helical anchorage 30. This fit is very strong and prevents replacement heart valve 10 from becoming dislodged. Figure 10C-1 is an even larger view showing a cell or aperture 24a of stent 24 that is fitted against foam and fabric covering 170, creating a very strong physical connection between these two components. Figure 10D illustrates a balloon catheter 140 expanding a replacement valve 10 into the coated helical anchorage 30 from an above view of the helical anchorage 30. Figure 10E illustrates the same view from above of the helical anchorage 30, but illustrating a full expansion of the valve 10 after inflation of the balloon catheter 140 (Fig. 10A). The stent portion 24 of the replacement heart valve 10 is then fully engaged with the resilient friction liner 170 in the helical anchorage 30.
[00137] Figures 11A to 11D illustrate an embodiment that includes a cover or coating 180 on the helical anchorage 30, which is intermittent, as opposed to the continuous coating 170 shown in the previous figures. In this sense, there are cladding segments 180 along the helical anchor 30, and these segments 180 can be rigidly fixed to the helical anchor 30. However, there can also be an advantage in allowing these segments 180 to slide along the helical anchor 30. , as the helical anchorage 30 is expanded, using, for example, a balloon inflation, as previously described. The segments 180 can slide along the spirals 32 of the helical anchorage 30 to allow the helical anchorage 30 to tighten and, at the same time, the segments 180 can snugly engage with the cells or openings 24a of the replacement heart valve stent. 24.
[00138] Figure 11A illustrates a helical anchor 30 with a cover that is intermittent and formed with segments 180. Cover segments 180 are shown with a taper at each end to allow the anchor 30 to be turned into position without an edge input flats hamper a placement. Tapering is not necessary, but it helps, if desired, in this regard. This taper may be of any suitable design and may be angled, or curved into any shape that promotes easy movement of the helical anchorage 30. A balloon catheter 140 is positioned within a stent-mounted replacement valve 10, as previously described and is beginning its inflation, as indicated by arrows 182. Figure 11B illustrates the replacement heart valve mounted with stent 10 fully expanded. Sheath segments 180 have become fully embedded in the cells or openings of the heart valve stent 24. Once these segments 180 engage with the stent 24 and enter one or more cells or openings, they become attached to the stent 24, and they will begin to slide along the helical anchorage 30. The helical anchorage 30 can expand and squeeze against the stent portion 24 of the replacement valve 10 and, at the same time, there will still be the beneficial effect of intermittent and strong attachment to the anchorage. helical 30 secured by segments 180 of high friction and resilient and/or compressible material. Figures 11C and 11D illustrate the process from above with the helical anchorage 30 showing an initial expansion of the stent mounted replacement heart valve 10 in Figure 11C and a full expansion and fit between segments 180 and stent 24 in Figure 11D securely affixing these two structures together during the implantation procedure on a patient.
[00139] Figures 12A to 12E illustrate a helical anchorage 30 and the motor or drive function provided when the helical anchorage 30 expands and the ends 30a, 30b of the spirals 32 move. Figure 12A illustrates a helical anchorage 30 with around four turns or spirals 32, while Figure 12B illustrates a helical anchorage 30 with around three turns or spirals 32. As further shown in Figure 12B, the helical anchorage 30 is affixed to burr fasteners 190 for shipment to a replacement heart valve 10. A fabric or other material or outer coating 192 is applied around burrs 190 around helical anchorage 30. When a balloon 140 is inflated into the anchorage helical 30, the two ends 30a, 30b of helical anchor 30 move in opposite directions as helical anchor 30 is expanded. In this way, the burrs 190 are oriented in opposite directions to the movement of the helical anchor 30, so that these burrs 190 are activated or move when the helical anchor 30 is expanded. Figure 12C illustrates a cross-section of the helical anchor 30 with the fabric or other covering or liner 192 and a fastener system 190 coupled with the helical anchor 30. It has been previously described how the turns or spirals 32 of the helical anchor 30 can be driven together by inflating a balloon 140. A balloon inflation also drives or moves turns 32 of helical anchorage 30 together, increasing the penetration of burrs 190. Burrs 190 in Figures 12B through 12E are oriented obliquely with respect to the geometric axis center of helical anchorage 30; however, burrs 190 may instead be employed in a straight or parallel direction to the geometric axis of the helical anchor 30, directly towards an adjacent turn or spiral 32 of the helical anchor 30, driven by the compression of the spirals. helicals 32 together by inflating the balloon 140. With an expansion, the ends 30a, 30b of the helical anchorage 30 move considerably, but the central portion of the anchorage 30 does not turn or rotate considerably. Burrs 190 without an oblique orientation may be preferred on the center spirals 32. The angle of burrs 190 may increase and their length may be increased in areas towards the ends 30a, 30b of the helical anchorage 30, where movement during an inflation of a balloon 140 is more pronounced. Figure 12D illustrates a top view of helical anchorage 30. As balloon catheter 140 is inflated, helical anchorage 30 increases in diameter and ends 30a, 30b of helical anchorage 30 rotate to allow for this expansion in diameter. As shown in Figure 12E, the expansion of the helical anchor 30 mobilized or employed the burrs 190, and the burrs 190 fit into the fabric or other coating of material 192 in the middle or center turn or spiral 32. This locks the turns or spirals 32 of the 30 helical anchorage together. No native valve cusp tissue is shown in Figure 12E; however, it will be appreciated that a cusp tissue could be located between the turns or spirals 32 and the burrs 190 could wrap and engage the cusp tissue for further attachment of the helical anchorage 30 to native mitral valve tissue.
[00140] Figures 13A to 13C illustrate another embodiment in which a helical anchor 30 is used having relatively larger diameter turns or spirals 32 at the ends of the anchor 30 and a relatively smaller turn or turns at a middle or central portion of the helical anchor 30. The helical anchor 30 is affixed to the burrs 190 and covered with a suitable backing material 192, such as a fabric or other material. When balloon 140 is inflated, the ends of helical anchor 30 begin to move, and burrs 190 are activated as the smaller central helical loop 30 is expanded outward. This particular arrangement is ideal for attachment to a patient's native mitral valve. A barred loop or spiral 32 of the helical anchorage 30 can be placed above the native mitral valve cusps and a barred loop or spiral 32 can be placed below the native mitral valve cusps. The smaller diameter loop or spiral 32 may sit above or below the native mitral valve cusps. When the balloon (not shown) is inflated, the large helical loops or spirals 32 above and below the native mitral valve cusps will be driven toward each other, as shown generally and described above in Figures 8A through 8D. Also, the anchor ends will rotate and burrs 190 will be employed through the mitral valve cusp tissue positioned between the larger loops or spirals 32 near the native annular space. The two large helical loops or spirals 32 can also be connected together as the burrs 190 cross the mitral tissue and penetrate the shroud 192 on the helical spiral 32 on the opposite side of the native mitral valve. These actions will trap the mitral valve between the turns or spirals 32 of the helical anchorage 30, although this need not be done. It is also evident that the large diameter loops or spirals 32 at the opposite ends of the helical anchorage 30 will become smaller in diameter as the balloon is expanded. In this sense, the upper and lower loops or spirals 32 “donate” to the middle spiral or loop 32. This will result in a reduction in diameter for the upper and lower spirals 32. After the spirals 32 have been secured to the perimeter or annular space of native mitral valve, this will result in a reduction in size of the mitral valve diameter, ie an annuloplasty procedure will result. When burrs 190 are firmly retained in native mitral valve tissue, they should not be dislodged or removed after penetration. Figure 13C illustrates a cross-sectional view of a helical anchor 30 from Figure 13B, as well as a burr system 190 and a liner 192, such as a fabric or other material. As previously described, burrs 190 can be employed directly from helical anchorage 30 at an angle of approximately 90° to spiral 32. This can be commanded simply by compressing spirals 32 to one another, as described above in relation to figures 8A to 8D. The movement of the helical spiral or turns of anchor 32 in a longitudinal or rotational manner also allows burrs 190 or other types of fasteners to be applied in a direction which is more parallel or oblique to the turns or spirals 32 of the helical anchor 30.
[00141] Figures 14A to 14C illustrate a different configuration for a helical anchorage 30. This anchorage 30 generally has four spirals 32. There are two upper spirals 32 followed by a joint segment 32a (slack segment). Junction segment 32a is typically used to separate the spirals 32 of anchorage 30 that lie above the a valve cusps from those below (in the atrium and ventricle, respectively). There is a spiral 32b of similar size as in the two upper spirals 32 at the end of the join segment 32a. This is the lowest spiral 32b at anchorage 30. The final spiral 32c changes direction - instead of continuing down, it spirals back to the back and overlaps or crosses an adjacent spiral 32 from anchorage 30. This spiral 32c it is shown as the “major convolution” in Figure 14B. The figure shows a change of direction (like the join segment) in the anchor 30 that allows the final spiral 32c to be directed upwards. The final spiral 32c is also larger to allow it to sit outside the other spirals. This larger spiral 32c is the middle spiral of the anchor 30, but is actually facing the native valve first when being shipped. The important feature of this anchorage 30 is that, as it is turned into position, the upward curve in the joint segment 32a forces the anchorage 30 upwards towards the annular space. This anchorage 30, when positioned with two spirals above and two spirals below the cusps, seats with the larger spiral 32c of anchorage 30 sitting directly under the mitral valve annular space. Anchorage 30 does not tend to fall into the ventricle. The lower spirals do not necessarily have to cross at the same point when viewed from the side (producing an X). They could be crossing, for example, on opposite sides.
[00142] The key element in the embodiment of figures 14A to 14C is that the return of the anchorage 30 into position will result in an upward movement of the end of the anchorage 30, which drives the anchorage 30 into position directly under the mitral valve. As this anchorage is “screwed” into the lowest spiral 32b, it forces the anchorage 30 upward against the mitral annular space. The larger 32c video spiral in the middle of anchor 30 also aids in positioning anchor 30 directly under the cusps and close to the annular space. The mitral annular space has a certain diameter, and by combining this diameter with the diameter of the larger anchoring spiral 32c, the anchorage 30 is able to sit directly under the annular space. If this spiral 32c is too small, the anchor 30 may drag against the cusp tissue and inhibit the anchor 30 from ascending into the annular space as it is placed. It will be appreciated that the crossing of spirals 32a, 32b in an anchorage 30 can also be useful for a valve anchorage when using an anchorage 30. The crossing of spiral 32a occurs in the lowest spiral of this anchorage 30. But a segment of crossover is used. - ment 32a could occur in any location. It could occur at the top, middle, or bottom of anchor 30. The amount of crossover could also vary. Here, the intersection includes the two lowest spirals 32. There could be more spirals that overlap. Here, the crossing includes the two lower spirals 32. There could be more spirals that overlap. Figure 14C shows the superposition spiral 32a with the lowest spiral being outward from the previous spirals. The 32a superposition spiral or the crossing segment could occur within the previous spirals. Figure 14C also shows an abrupt change in pitch to cause an overlap. Overlap can also occur with a smooth change of pitch. In Figures 14A to 14C, the spacing between the spirals in both the top to bottom and the side-to-side dimensions are exaggerated for clarity. The spirals will apply compression from the top and bottom towards the center.
[00143] A major advantage of the configuration shown in Figures 14A to 14C is that the number of coils 32 available for attachment to the valve is increased, but the length of the anchorage 30 does not increase. This allows for a shorter anchorage. For example, it may be useful to have less anchorage length positioned in the left ventricle 40 so that the valve 10 can sit more towards the atrium 42. The overlapping or crossing spirals 32a can intersect in a desired manner and allow that the valve 10 be retained with a strong force and a shorter overall length within the left ventricle 40. The superposition 32a on the anchor could also be positioned at the level where the native cusps 12a, 12b are settling. This would increase the trapping of the cusps 12a, 12b - the anchor 30 could be positioned so that the overlapping spirals have a cusp between them. If the clearance between the spirals 32 of the anchorage 30 were small enough, the cusps 12a, 12b could be trapped between the spirals 32 without the need for additional fasteners. This arrangement can also position the cusps 12a, 12b to be secured to anchor 30 or to an anchorage system attached or guided by anchor 30. This particular anchoring arrangement is also useful, because the lower spiral of anchoring spirals 32 se extends in the opposite direction to the rest of the anchor 30 - while the other spirals 32 are oriented downwards, this is oriented upwards. As this anchor 30 is turned into position, the lower spiral 32b will tend to move back up. This is actually creating a virtual reverse donut. A typical helical anchor is threaded into valve cusps 12a, 12b like a corkscrew and, as it is turned, moves downward. With this configuration, once the first spiral of the anchor 30 is turned towards the valve 12 and the splice segment 32a is reached, the anchor 30 will actually start to turn up, rather than down, as the lower spiral 32b is being turned over. This means that this particular anchorage arrangement will tend to seat directly under the annular space 12. This is useful in optimally positioning the anchorage 30 near the underside of the annular space 12. An anchorage 30 affixed to the cusps 12a, 12b to away from the annular space 12 it will tend to move and wobble as the heart contracts. This is because of a cusp movement away from the annular space 12 as the heart beats. In contrast, annular space 12 moves very little as the heart beats. By positioning anchor 30 closer to annular space 12 (away from the cusps), the amount of movement of anchor 30 is reduced. Each day, the heart beats around 100,000 times. This repetitive movement will produce a risk of dislodgement of the anchor and valve. Thus, a minimization of movement by placing the anchorage 30 close to the annular space 12 will reduce the risk of a valve implant failure. In Figures 14A to 14C, the crossing points for the anchoring spirals 32 are both on the same side of the anchoring 30. This creates an X. It is not necessary for the crossing points to occur on the same side. For example, they could be on opposite sides of anchor 30.
[00144] Although the present invention has been illustrated by a description of preferred embodiments, and although these embodiments have been described in some detail, it is not the Applicants' intent to restrict or in any way limit the scope of the appended claims to this detail. Additional advantages and modifications will readily appear to those skilled in the art. The various features and concepts of the invention can be used alone or in any combination, depending on the needs and preferences of the operator. This was a description of the present invention, along with preferred methods of practicing the present invention, as currently known. However, the invention itself is to be defined only by the appended claims.

权利要求:
Claims (22)
[0001]
1. System for replacing a native heart valve, the system characterized in that it comprises: an expandable helical anchor (30) formed as multiple spirals (32) adapted to support a heart valve prosthesis (10), a first spiral into a first diameter and being expandable to a larger second diameter by applying an outward radial force from within the helical anchor (30), wherein a portion of a middle spiral is located between a first end of the helical anchor (30) and a second end of the helical anchor (30) opposite the first end of the helical anchor (30), wherein the portion of a middle spiral has a diameter smaller than a diameter of the first end of the helical anchor (30) and less than a diameter of the second end of the helical anchor (30), and wherein the expandable heart valve prosthesis (10) is capable of being sent to the helical anchor (30) and expand. shaped within the multiple spirals (32) being configured to move the first spiral from the first diameter to the second diameter, while the helical anchor (30) and the heart valve prosthesis (10) are secured together, wherein at least one compressible element in the helical anchorage (30), wherein the compressible element is fitted by the heart valve prosthesis (10) as the heart valve prosthesis (10) is expanded within the multiple spirals (32) wherein said prosthesis expansion The heart valve prosthesis (10) within the multiple coils (32) is configured to assist in affixing the heart valve prosthesis to the helical anchorage (30), wherein the heart valve prosthesis (10) comprises an expandable structure including apertures, the openings are fitted by at least one compressible element as the heart valve prosthesis is expanded within the multiple spirals (32).
[0002]
2. System for replacement of a native heart valve, according to claim 1, characterized in that the helical anchorage (30) includes a spiral that moves from a larger diameter to a smaller diameter according to the valve prosthesis heart (10) is expanded within the multiple spirals (32).
[0003]
3. System for replacement of a native heart valve, according to claim 2, characterized in that at least two adjacent spirals of the helical anchorage (30) are spaced, in which adjacent spirals move towards each other according to heart valve prosthesis (10) is expanded within the multiple spirals (32).
[0004]
4. System for replacement of a native heart valve, according to claim 1, characterized in that the helical anchorage (30) comprises a plurality of fasteners, in which the fasteners are moved from an undeployed state to an implanted state as the first spiral moves from the first diameter to the second largest diameter.
[0005]
5. System for replacement of a native heart valve, according to claim 4, characterized in that it comprises a seal (50) coupled to the helical anchor (30) and that includes portions extending between adjacent spirals, configured to avoid a blood leak through the helical anchorage and heart valve prosthesis (10), wherein the fasteners engage the seal (50) in the implanted state.
[0006]
6. System for replacing a native heart valve, according to claim 1, characterized in that at least one compressible element comprises multiple compressible elements spaced along the multiple spirals (32).
[0007]
7. System for replacement of a native heart valve, according to claim 1, characterized in that at least one compressible element comprises a continuous compressible element that extends along multiple spirals (32).
[0008]
8. System for replacing a native heart valve, according to claim 1, characterized in that at least one compressible element comprises a resilient material.
[0009]
9. System for replacing a native heart valve, according to claim 1, characterized in that the at least one compressible element comprises a coating comprising a fabric material disposed on the resilient material, wherein the resilient element comprises a foam material.
[0010]
10. System for replacing a native heart valve, according to claim 1, characterized in that the at least one compressible element comprises a coating comprising a fabric material disposed on the resilient material, wherein the resilient element comprises a polymer material.
[0011]
11. System for replacement of a native heart valve, according to claim 1, characterized in that the multiple spirals (32) of the helical anchorage (30) include at least two spirals that cross one another.
[0012]
12. System for replacement of a native heart valve, according to claim 1, characterized in that the helical anchor (30) comprises a material with shape memory.
[0013]
13. System for replacing a native heart valve, according to claim 1, characterized in that it comprises a seal (50) coupled to the helical anchor (30) and including portions extending between adjacent spirals configured to prevent leakage of blood through the helical anchorage (30) and in front of the heart valve prosthesis (10).
[0014]
14. System for replacement of a native heart valve, according to claim 13, characterized in that the seal (50) comprises a membrane or a panel (110) that extends over at least two spirals of the helical anchorage (30 ).
[0015]
15. System for replacing a native heart valve, according to claim 14, characterized in that the membrane or panel (110) is moved between an undeployed state and an implanted state, in which the undeployed state is adapted for shipment to an implantation site and the implanted state is adapted for implantation of the system and anchorage of the heart valve prosthesis (10).
[0016]
16. System for replacement of a native heart valve, according to claim 15, characterized in that the non-implanted state comprises a collapsed state.
[0017]
17. System for replacing a native heart valve, according to claim 14, characterized in that the membrane or panel (110) includes a support element (112).
[0018]
18. System for replacement of a native heart valve, according to claim 13, characterized in that the seal (50) comprises one or more seal elements (52a, 52b, 52c) carried by the helical anchorage (30) and includes overlapping portions configured to seal a space between adjacent spirals of the helical anchor (30).
[0019]
19. System for replacing a native heart valve, according to claim 18, characterized in that at least one seal element (52a, 52b, 52c) has an affixed support element.
[0020]
20. System for replacing a native heart valve, according to claim 18, characterized in that at least one seal element (52a, 52b, 52c) is configured with a circular cross-section.
[0021]
21. System for replacement of a native heart valve, according to claim 18, characterized in that at least one seal element (52a, 52b, 52c) is configured with an oblong-shaped cross section (70).
[0022]
22. System for replacement of a native heart valve, according to claim 18, characterized in that at least one seal element (52a, 52b, 52c) has a connecting portion (86) affixed to one of the spirals and it has an extension portion that extends toward an adjacent spiral.

类似技术:

---

公开号 | 公开日 | 专利标题

---

BR112016002887B1|2021-05-25|system for replacing a native heart valve

---

JP6974335B2|2021-12-01|Devices, systems, and methods for transcatheter treatment of valve regurgitation

---

CN106132352B|2018-11-16|Cardiac valve replacement device and method

---

CN101184453B|2012-07-04|A blood flow controlling apparatus

---

US9023065B2|2015-05-05|Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ

---

EP3508173A1|2019-07-10|Systems for placing a coaptation member between valvular leaflets

---

EP2994072A1|2016-03-16|Heart valve assistive prosthesis

---

JP2007530136A5|2012-08-30|

---

AU2011253682B2|2013-10-03|Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ

---

CN110891524A|2020-03-17|Method and system for assisting or repairing a prosthetic heart valve

---

WO2018145249A1|2018-08-16|Device for treating regurgitation of tricuspid valve and implantation method therefor

---

JP7015609B2|2022-02-03|Heart valve replacement system and its method

---

CN114209471A|2022-03-22|Heart valve replacement devices and methods

同族专利:

---

公开号 | 公开日

---

JP6876664B2|2021-05-26|

---

EP3033049A4|2017-05-03|

---

US10034749B2|2018-07-31|

---

BR112016002887A2|2017-08-01|

---

JP6430508B2|2018-11-28|

---

US20210186691A1|2021-06-24|

---

JP2021079141A|2021-05-27|

---

SG11201601029WA|2016-03-30|

---

CN105682610A|2016-06-15|

---

US20180271652A1|2018-09-27|

---

WO2015023579A1|2015-02-19|

---

SG10201805117UA|2018-07-30|

---

JP2019030730A|2019-02-28|

---

CR20160095A|2016-12-05|

---

EP3033049A1|2016-06-22|

---

US20160199177A1|2016-07-14|

---

CN105682610B|2017-11-03|

---

BR112016002887A8|2020-01-28|

---

CN107744416A|2018-03-02|

---

US10945837B2|2021-03-16|

---

JP2016529995A|2016-09-29|

---

CN113616381A|2021-11-09|

---

SG10202103500PA|2021-05-28|

---

CA2920724A1|2015-02-19|

---

CN107744416B|2021-08-31|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

GB1127325A|1965-08-23|1968-09-18|Henry Berry|Improved instrument for inserting artificial heart valves|

---

US3587115A|1966-05-04|1971-06-28|Donald P Shiley|Prosthetic sutureless heart valves and implant tools therefor|

---

US3548417A|1967-09-05|1970-12-22|Ronnie G Kischer|Heart valve having a flexible wall which rotates between open and closed positions|

---

USRE30912E|1968-09-16|1982-04-27|Hancock Laboratories, Inc.|Stent for heart valve|

---

US3671979A|1969-09-23|1972-06-27|Univ Utah|Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve|

---

US3657744A|1970-05-08|1972-04-25|Univ Minnesota|Method for fixing prosthetic implants in a living body|

---

US3714671A|1970-11-30|1973-02-06|Cutter Lab|Tissue-type heart valve with a graft support ring or stent|

---

US3755823A|1971-04-23|1973-09-04|Hancock Laboratories Inc|Flexible stent for heart valve|

---

US4035849A|1975-11-17|1977-07-19|William W. Angell|Heart valve stent and process for preparing a stented heart valve prosthesis|

---

US4297749A|1977-04-25|1981-11-03|Albany International Corp.|Heart valve prosthesis|

---

CA1069652A|1976-01-09|1980-01-15|Alain F. Carpentier|Supported bioprosthetic heart valve with compliant orifice ring|

---

US4056854A|1976-09-28|1977-11-08|The United States Of America As Represented By The Department Of Health, Education And Welfare|Aortic heart valve catheter|

---

US4222126A|1978-12-14|1980-09-16|The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare|Unitized three leaflet heart valve|

---

US4265694A|1978-12-14|1981-05-05|The United States Of America As Represented By The Department Of Health, Education And Welfare|Method of making unitized three leaflet heart valve|

---

US4574803A|1979-01-19|1986-03-11|Karl Storz|Tissue cutter|

---

GB2056023B|1979-08-06|1983-08-10|Ross D N Bodnar E|Stent for a cardiac valve|

---

US4373216A|1980-10-27|1983-02-15|Hemex, Inc.|Heart valves having edge-guided occluders|

---

US4388735A|1980-11-03|1983-06-21|Shiley Inc.|Low profile prosthetic xenograft heart valve|

---

US4339831A|1981-03-27|1982-07-20|Medtronic, Inc.|Dynamic annulus heart valve and reconstruction ring|

---

US4470157A|1981-04-27|1984-09-11|Love Jack W|Tricuspid prosthetic tissue heart valve|

---

US4345340A|1981-05-07|1982-08-24|Vascor, Inc.|Stent for mitral/tricuspid heart valve|

---

US4406022A|1981-11-16|1983-09-27|Kathryn Roy|Prosthetic valve means for cardiovascular surgery|

---

SE445884B|1982-04-30|1986-07-28|Medinvent Sa|DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION|

---

GB8300636D0|1983-01-11|1983-02-09|Black M M|Heart valve replacements|

---

US4535483A|1983-01-17|1985-08-20|Hemex, Inc.|Suture rings for heart valves|

---

US4612011A|1983-07-22|1986-09-16|Hans Kautzky|Central occluder semi-biological heart valve|

---

US4787899A|1983-12-09|1988-11-29|Lazarus Harrison M|Intraluminal graft device, system and method|

---

US4627436A|1984-03-01|1986-12-09|Innoventions Biomedical Inc.|Angioplasty catheter and method for use thereof|

---

US4592340A|1984-05-02|1986-06-03|Boyles Paul W|Artificial catheter means|

---

US5007896A|1988-12-19|1991-04-16|Surgical Systems & Instruments, Inc.|Rotary-catheter for atherectomy|

---

US4979939A|1984-05-14|1990-12-25|Surgical Systems & Instruments, Inc.|Atherectomy system with a guide wire|

---

DE3426300C2|1984-07-17|1987-12-03|Doguhan Dr.Med. 2800 Bremen De Baykut|

---

DE3442088A1|1984-11-17|1986-05-28|Beiersdorf Ag, 2000 Hamburg|HEART VALVE PROSTHESIS|

---

US4759758A|1984-12-07|1988-07-26|Shlomo Gabbay|Prosthetic heart valve|

---

FR2587614B1|1985-09-23|1988-01-15|Biomasys Sa|PROSTHETIC HEART VALVE|

---

US4733665C2|1985-11-07|2002-01-29|Expandable Grafts Partnership|Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft|

---

DE3640745A1|1985-11-30|1987-06-04|Ernst Peter Prof Dr M Strecker|Catheter for producing or extending connections to or between body cavities|

---

CH672247A5|1986-03-06|1989-11-15|Mo Vysshee Tekhnicheskoe Uchil|

---

US4878906A|1986-03-25|1989-11-07|Servetus Partnership|Endoprosthesis for repairing a damaged vessel|

---

US4883458A|1987-02-24|1989-11-28|Surgical Systems & Instruments, Inc.|Atherectomy system and method of using the same|

---

US4777951A|1986-09-19|1988-10-18|Mansfield Scientific, Inc.|Procedure and catheter instrument for treating patients for aortic stenosis|

---

US4762128A|1986-12-09|1988-08-09|Advanced Surgical Intervention, Inc.|Method and apparatus for treating hypertrophy of the prostate gland|

---

US4878495A|1987-05-15|1989-11-07|Joseph Grayzel|Valvuloplasty device with satellite expansion means|

---

US4796629A|1987-06-03|1989-01-10|Joseph Grayzel|Stiffened dilation balloon catheter device|

---

US4829990A|1987-06-25|1989-05-16|Thueroff Joachim|Implantable hydraulic penile erector|

---

US4851001A|1987-09-17|1989-07-25|Taheri Syde A|Prosthetic valve for a blood vein and an associated method of implantation of the valve|

---

US5266073A|1987-12-08|1993-11-30|Wall W Henry|Angioplasty stent|

---

US5032128A|1988-07-07|1991-07-16|Medtronic, Inc.|Heart valve prosthesis|

---

DE8815082U1|1988-11-29|1989-05-18|Biotronik Mess- Und Therapiegeraete Gmbh & Co Ingenieurbuero Berlin, 1000 Berlin, De|

---

US4856516A|1989-01-09|1989-08-15|Cordis Corporation|Endovascular stent apparatus and method|

---

US4966604A|1989-01-23|1990-10-30|Interventional Technologies Inc.|Expandable atherectomy cutter with flexibly bowed blades|

---

US4994077A|1989-04-21|1991-02-19|Dobben Richard L|Artificial heart valve for implantation in a blood vessel|

---

US5609626A|1989-05-31|1997-03-11|Baxter International Inc.|Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts|

---

DK0474748T3|1989-05-31|1995-05-01|Baxter Int|Biological flap prosthesis|

---

US5047041A|1989-08-22|1991-09-10|Samuels Peter B|Surgical apparatus for the excision of vein valves in situ|

---

US4986830A|1989-09-22|1991-01-22|Schneider Inc.|Valvuloplasty catheter with balloon which remains stable during inflation|

---

US5089015A|1989-11-28|1992-02-18|Promedica International|Method for implanting unstented xenografts and allografts|

---

US5591185A|1989-12-14|1997-01-07|Corneal Contouring Development L.L.C.|Method and apparatus for reprofiling or smoothing the anterior or stromal cornea by scraping|

---

US5037434A|1990-04-11|1991-08-06|Carbomedics, Inc.|Bioprosthetic heart valve with elastic commissures|

---

US5059177A|1990-04-19|1991-10-22|Cordis Corporation|Triple lumen balloon catheter|

---

US5085635A|1990-05-18|1992-02-04|Cragg Andrew H|Valved-tip angiographic catheter|

---

US5411552A|1990-05-18|1995-05-02|Andersen; Henning R.|Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis|

---

DK124690D0|1990-05-18|1990-05-18|Henning Rud Andersen|FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION|

---

US5152771A|1990-12-31|1992-10-06|The Board Of Supervisors Of Louisiana State University|Valve cutter for arterial by-pass surgery|

---

US5282847A|1991-02-28|1994-02-01|Medtronic, Inc.|Prosthetic vascular grafts with a pleated structure|

---

JPH05184611A|1991-03-19|1993-07-27|Kenji Kusuhara|Valvular annulation retaining member and its attaching method|

---

US5295958A|1991-04-04|1994-03-22|Shturman Cardiology Systems, Inc.|Method and apparatus for in vivo heart valve decalcification|

---

US5167628A|1991-05-02|1992-12-01|Boyles Paul W|Aortic balloon catheter assembly for indirect infusion of the coronary arteries|

---

US5397351A|1991-05-13|1995-03-14|Pavcnik; Dusan|Prosthetic valve for percutaneous insertion|

---

US5769812A|1991-07-16|1998-06-23|Heartport, Inc.|System for cardiac procedures|

---

US5558644A|1991-07-16|1996-09-24|Heartport, Inc.|Retrograde delivery catheter and method for inducing cardioplegic arrest|

---

US5584803A|1991-07-16|1996-12-17|Heartport, Inc.|System for cardiac procedures|

---

US5370685A|1991-07-16|1994-12-06|Stanford Surgical Technologies, Inc.|Endovascular aortic valve replacement|

---

US5192297A|1991-12-31|1993-03-09|Medtronic, Inc.|Apparatus and method for placement and implantation of a stent|

---

US5756476A|1992-01-14|1998-05-26|The United States Of America As Represented By The Department Of Health And Human Services|Inhibition of cell proliferation using antisense oligonucleotides|

---

US5163953A|1992-02-10|1992-11-17|Vince Dennis J|Toroidal artificial heart valve stent|

---

US5683448A|1992-02-21|1997-11-04|Boston Scientific Technology, Inc.|Intraluminal stent and graft|

---

US5628792A|1992-03-13|1997-05-13|Jcl Technic Ab|Cardiac valve with recessed valve flap hinges|

---

US5332402A|1992-05-12|1994-07-26|Teitelbaum George P|Percutaneously-inserted cardiac valve|

---

DE4327825C2|1992-11-24|1996-10-02|Mannesmann Ag|Throttle check element|

---

US6346074B1|1993-02-22|2002-02-12|Heartport, Inc.|Devices for less invasive intracardiac interventions|

---

GB9312666D0|1993-06-18|1993-08-04|Vesely Ivan|Bioprostetic heart valve|

---

CA2125258C|1993-08-05|1998-12-22|Dinah B Quiachon|Multicapsule intraluminal grafting system and method|

---

US5545209A|1993-09-30|1996-08-13|Texas Petrodet, Inc.|Controlled deployment of a medical device|

---

US5480424A|1993-11-01|1996-01-02|Cox; James L.|Heart valve replacement using flexible tubes|

---

US5609627A|1994-02-09|1997-03-11|Boston Scientific Technology, Inc.|Method for delivering a bifurcated endoluminal prosthesis|

---

US5728068A|1994-06-14|1998-03-17|Cordis Corporation|Multi-purpose balloon catheter|

---

US5554185A|1994-07-18|1996-09-10|Block; Peter C.|Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same|

---

US5599305A|1994-10-24|1997-02-04|Cardiovascular Concepts, Inc.|Large-diameter introducer sheath having hemostasis valve and removable steering mechanism|

---

US5639274A|1995-06-02|1997-06-17|Fischell; Robert E.|Integrated catheter system for balloon angioplasty and stent delivery|

---

US5716417A|1995-06-07|1998-02-10|St. Jude Medical, Inc.|Integral supporting structure for bioprosthetic heart valve|

---

US5571175A|1995-06-07|1996-11-05|St. Jude Medical, Inc.|Suture guard for prosthetic heart valve|

---

DE19532846A1|1995-09-06|1997-03-13|Georg Dr Berg|Valve for use in heart|

---

US5591195A|1995-10-30|1997-01-07|Taheri; Syde|Apparatus and method for engrafting a blood vessel|

---

EP0808614B1|1996-05-23|2003-02-26|Samsung Electronics Co., Ltd.|Flexible self-expandable stent and method for making the same|

---

US5855601A|1996-06-21|1999-01-05|The Trustees Of Columbia University In The City Of New York|Artificial heart valve and method and device for implanting the same|

---

GB9614950D0|1996-07-16|1996-09-04|Anson Medical Ltd|A ductus stent and delivery catheter|

---

US6217585B1|1996-08-16|2001-04-17|Converge Medical, Inc.|Mechanical stent and graft delivery system|

---

JP3968444B2|1996-08-23|2007-08-29|ボストンサイエンティフィックサイムド，インコーポレイテッド|Stent delivery mechanism with stent fixation device|

---

US5855602A|1996-09-09|1999-01-05|Shelhigh, Inc.|Heart valve prosthesis|

---

US5968068A|1996-09-12|1999-10-19|Baxter International Inc.|Endovascular delivery system|

---

US5749890A|1996-12-03|1998-05-12|Shaknovich; Alexander|Method and system for stent placement in ostial lesions|

---

NL1004827C2|1996-12-18|1998-06-19|Surgical Innovations Vof|Device for regulating blood circulation.|

---

EP0850607A1|1996-12-31|1998-07-01|Cordis Corporation|Valve prosthesis for implantation in body channels|

---

GB9701479D0|1997-01-24|1997-03-12|Aortech Europ Ltd|Heart valve|

---

US5957949A|1997-05-01|1999-09-28|World Medical Manufacturing Corp.|Percutaneous placement valve stent|

---

US6206917B1|1997-05-02|2001-03-27|St. Jude Medical, Inc.|Differential treatment of prosthetic devices|

---

US6245102B1|1997-05-07|2001-06-12|Iowa-India Investments Company Ltd.|Stent, stent graft and stent valve|

---

US5855597A|1997-05-07|1999-01-05|Iowa-India Investments Co. Limited|Stent valve and stent graft for percutaneous surgery|

---

US5925063A|1997-09-26|1999-07-20|Khosravi; Farhad|Coiled sheet valve, filter or occlusive device and methods of use|

---

US6769161B2|1997-10-16|2004-08-03|Scimed Life Systems, Inc.|Radial stent crimper|

---

AU2011699A|1997-12-29|1999-07-19|Ivan Vesely|System for minimally invasive insertion of a bioprosthetic heart valve|

---

US6174327B1|1998-02-27|2001-01-16|Scimed Life Systems, Inc.|Stent deployment apparatus and method|

---

SG76636A1|1998-12-22|2000-11-21|Medinol Ltd|Apparatus and method for securing a stent on a balloon|

---

US6350277B1|1999-01-15|2002-02-26|Scimed Life Systems, Inc.|Stents with temporary retaining bands|

---

EP1143882B1|1999-01-26|2007-12-05|Edwards Lifesciences Corporation|Flexible heart valve|

---

US6896690B1|2000-01-27|2005-05-24|Viacor, Inc.|Cardiac valve procedure methods and devices|

---

US6425916B1|1999-02-10|2002-07-30|Michi E. Garrison|Methods and devices for implanting cardiac valves|

---

DE19907646A1|1999-02-23|2000-08-24|Georg Berg|Valve for blood vessels uses flap holders and counterpart holders on stent to latch together in place and all channeled for guide wire.|

---

US6210408B1|1999-02-24|2001-04-03|Scimed Life Systems, Inc.|Guide wire system for RF recanalization of vascular blockages|

---

US6231602B1|1999-04-16|2001-05-15|Edwards Lifesciences Corporation|Aortic annuloplasty ring|

---

WO2000064381A2|1999-04-28|2000-11-02|St. Jude Medical, Inc.|Heart valve prostheses|

---

US6858034B1|1999-05-20|2005-02-22|Scimed Life Systems, Inc.|Stent delivery system for prevention of kinking, and method of loading and using same|

---

US7628803B2|2001-02-05|2009-12-08|Cook Incorporated|Implantable vascular device|

---

US6299637B1|1999-08-20|2001-10-09|Samuel M. Shaolian|Transluminally implantable venous valve|

---

US6527979B2|1999-08-27|2003-03-04|Corazon Technologies, Inc.|Catheter systems and methods for their use in the treatment of calcified vascular occlusions|

---

US6352547B1|1999-09-22|2002-03-05|Scimed Life Systems, Inc.|Stent crimping system|

---

FR2800984B1|1999-11-17|2001-12-14|Jacques Seguin|DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY|

---

US7018406B2|1999-11-17|2006-03-28|Corevalve Sa|Prosthetic valve for transluminal delivery|

---

US6458153B1|1999-12-31|2002-10-01|Abps Venture One, Ltd.|Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof|

---

JP2004500189A|2000-01-31|2004-01-08|クック・バイオテック・インコーポレーテッド|Stent valve and method of using the same|

---

US20050070999A1|2000-02-02|2005-03-31|Spence Paul A.|Heart valve repair apparatus and methods|

---

US6797002B2|2000-02-02|2004-09-28|Paul A. Spence|Heart valve repair apparatus and methods|

---

US6454799B1|2000-04-06|2002-09-24|Edwards Lifesciences Corporation|Minimally-invasive heart valves and methods of use|

---

US20050043757A1|2000-06-12|2005-02-24|Michael Arad|Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof|

---

US7077861B2|2000-07-06|2006-07-18|Medtentia Ab|Annuloplasty instrument|

---

US6419696B1|2000-07-06|2002-07-16|Paul A. Spence|Annuloplasty devices and related heart valve repair methods|

---

US7510572B2|2000-09-12|2009-03-31|Shlomo Gabbay|Implantation system for delivery of a heart valve prosthesis|

---

WO2002022054A1|2000-09-12|2002-03-21|Gabbay S|Valvular prosthesis and method of using same|

---

US6461382B1|2000-09-22|2002-10-08|Edwards Lifesciences Corporation|Flexible heart valve having moveable commissures|

---

DE10047614C2|2000-09-26|2003-03-27|Generis Gmbh|Device for building up models in layers|

---

FR2815844B1|2000-10-31|2003-01-17|Jacques Seguin|TUBULAR SUPPORT FOR THE PERCUTANEOUS POSITIONING OF A REPLACEMENT HEART VALVE|

---

US6482228B1|2000-11-14|2002-11-19|Troy R. Norred|Percutaneous aortic valve replacement|

---

US6440764B1|2000-11-22|2002-08-27|Agere Systems Guardian Corp.|Enhancement of carrier concentration in As-containing contact layers|

---

WO2002047575A2|2000-12-15|2002-06-20|Angiomed Gmbh & Co. Medizintechnik Kg|Stent with valve|

---

US6716244B2|2000-12-20|2004-04-06|Carbomedics, Inc.|Sewing cuff assembly for heart valves|

---

US6468660B2|2000-12-29|2002-10-22|St. Jude Medical, Inc.|Biocompatible adhesives|

---

US6783542B2|2001-02-22|2004-08-31|Scimed Life Systems, Inc|Crimpable balloon/stent protector|

---

US6503272B2|2001-03-21|2003-01-07|Cordis Corporation|Stent-based venous valves|

---

US6733525B2|2001-03-23|2004-05-11|Edwards Lifesciences Corporation|Rolled minimally-invasive heart valves and methods of use|

---

US7374571B2|2001-03-23|2008-05-20|Edwards Lifesciences Corporation|Rolled minimally-invasive heart valves and methods of manufacture|

---

DE60209583T2|2001-03-30|2006-12-21|Terumo K.K.|stent|

---

US7037334B1|2001-04-24|2006-05-02|Mitralign, Inc.|Method and apparatus for catheter-based annuloplasty using local plications|

---

CA2445994A1|2001-05-01|2002-11-07|Asghar Khaghani|Valve prosthesis|

---

US6488704B1|2001-05-07|2002-12-03|Biomed Solutions, Llc|Implantable particle measuring apparatus|

---

US6936067B2|2001-05-17|2005-08-30|St. Jude Medical Inc.|Prosthetic heart valve with slit stent|

---

EP1521550A4|2002-06-12|2011-02-23|Mitral Interventions Inc|Method and apparatus for tissue connection|

---

EP1432369B1|2001-08-31|2008-02-27|Mitral Interventions|Apparatus for valve repair|

---

US7556646B2|2001-09-13|2009-07-07|Edwards Lifesciences Corporation|Methods and apparatuses for deploying minimally-invasive heart valves|

---

AU2003277115A1|2002-10-01|2004-04-23|Ample Medical, Inc.|Device and method for repairing a native heart valve leaflet|

---

US6893460B2|2001-10-11|2005-05-17|Percutaneous Valve Technologies Inc.|Implantable prosthetic valve|

---

AU2002347579A1|2001-11-23|2003-06-10|Mindguard Ltd.|Expandable delivery appliance particularly for delivering intravascular devices|

---

EP1494611A2|2002-03-11|2005-01-12|John L. Wardle|Surgical coils and methods of deploying|

---

US7141064B2|2002-05-08|2006-11-28|Edwards Lifesciences Corporation|Compressed tissue for heart valve leaflets|

---

US20040024452A1|2002-08-02|2004-02-05|Kruse Steven D.|Valved prostheses with preformed tissue leaflets|

---

US6878162B2|2002-08-30|2005-04-12|Edwards Lifesciences Ag|Helical stent having improved flexibility and expandability|

---

JP2006526464A|2003-06-05|2006-11-24|フローメディカ，インコーポレイテッド|System and method for performing bilateral intervention or diagnosis in a branched body lumen|

---

US7137184B2|2002-09-20|2006-11-21|Edwards Lifesciences Corporation|Continuous heart valve support frame and method of manufacture|

---

US20050119735A1|2002-10-21|2005-06-02|Spence Paul A.|Tissue fastening systems and methods utilizing magnetic guidance|

---

US7316710B1|2002-12-30|2008-01-08|Advanced Cardiovascular Systems, Inc.|Flexible stent|

---

US7399315B2|2003-03-18|2008-07-15|Edwards Lifescience Corporation|Minimally-invasive heart valve with cusp positioners|

---

US7096554B2|2003-04-04|2006-08-29|Boston Scientific Scimed, Inc.|Protective loading of stents|

---

EP2133039B1|2003-04-24|2014-10-08|Cook Medical Technologies LLC|Artificial valve prosthesis with improved flow dynamics|

---

US7959665B2|2003-07-31|2011-06-14|Abbott Cardiovascular Systems Inc.|Intravascular stent with inverted end rings|

---

US8021421B2|2003-08-22|2011-09-20|Medtronic, Inc.|Prosthesis heart valve fixturing device|

---

US20050075725A1|2003-10-02|2005-04-07|Rowe Stanton J.|Implantable prosthetic valve with non-laminar flow|

---

US20060259137A1|2003-10-06|2006-11-16|Jason Artof|Minimally invasive valve replacement system|

---

US20050075712A1|2003-10-06|2005-04-07|Brian Biancucci|Minimally invasive valve replacement system|

---

US7553324B2|2003-10-14|2009-06-30|Xtent, Inc.|Fixed stent delivery devices and methods|

---

US7959666B2|2003-12-23|2011-06-14|Sadra Medical, Inc.|Methods and apparatus for endovascularly replacing a heart valve|

---

US20050137691A1|2003-12-23|2005-06-23|Sadra Medical|Two piece heart valve and anchor|

---

US20050137686A1|2003-12-23|2005-06-23|Sadra Medical, A Delaware Corporation|Externally expandable heart valve anchor and method|

---

US8182528B2|2003-12-23|2012-05-22|Sadra Medical, Inc.|Locking heart valve anchor|

---

US8828078B2|2003-12-23|2014-09-09|Sadra Medical, Inc.|Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements|

---

EP1718246A4|2004-02-05|2009-11-18|Childrens Medical Center|Transcatheter delivery of a replacement heart valve|

---

US7311730B2|2004-02-13|2007-12-25|Shlomo Gabbay|Support apparatus and heart valve prosthesis for sutureless implantation|

---

US7225518B2|2004-02-23|2007-06-05|Boston Scientific Scimed, Inc.|Apparatus for crimping a stent assembly|

---

US7207204B2|2004-02-26|2007-04-24|Boston Scientific Scimed, Inc.|Crimper|

---

CA2557657C|2004-02-27|2013-06-18|Aortx, Inc.|Prosthetic heart valve delivery systems and methods|

---

WO2005087140A1|2004-03-11|2005-09-22|Percutaneous Cardiovascular Solutions Pty Limited|Percutaneous heart valve prosthesis|

---

EP1753374A4|2004-04-23|2010-02-10|3F Therapeutics Inc|Implantable prosthetic valve|

---

WO2006007401A2|2004-06-16|2006-01-19|Machine Solutions, Inc.|Tissue prothesis processing technology|

---

US7276078B2|2004-06-30|2007-10-02|Edwards Lifesciences Pvt|Paravalvular leak detection, sealing, and prevention|

---

US7462191B2|2004-06-30|2008-12-09|Edwards Lifesciences Pvt, Inc.|Device and method for assisting in the implantation of a prosthetic valve|

---

US7704277B2|2004-09-14|2010-04-27|Edwards Lifesciences Ag|Device and method for treatment of heart valve regurgitation|

---

CA3050938C|2004-10-02|2021-10-19|Edwards Lifesciences Cardiaq Llc|Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support|

---

US7316148B2|2005-02-15|2008-01-08|Boston Scientific Scimed, Inc.|Protective sheet loader|

---

CN102247225B|2005-02-28|2015-07-22|梅德坦提亚国际有限公司|Device for improving the function of heart valve and kit|

---

US8083793B2|2005-02-28|2011-12-27|Medtronic, Inc.|Two piece heart valves including multiple lobe valves and methods for implanting them|

---

US8062359B2|2005-04-06|2011-11-22|Edwards Lifesciences Corporation|Highly flexible heart valve connecting band|

---

SE531468C2|2005-04-21|2009-04-14|Edwards Lifesciences Ag|An apparatus for controlling blood flow|

---

US7914569B2|2005-05-13|2011-03-29|Medtronics Corevalve Llc|Heart valve prosthesis and methods of manufacture and use|

---

CN101180010B|2005-05-24|2010-12-01|爱德华兹生命科学公司|Rapid deployment prosthetic heart valve|

---

US7238200B2|2005-06-03|2007-07-03|Arbor Surgical Technologies, Inc.|Apparatus and methods for making leaflets and valve prostheses including such leaflets|

---

US7780723B2|2005-06-13|2010-08-24|Edwards Lifesciences Corporation|Heart valve delivery system|

---

EP1922030B1|2005-09-07|2015-12-30|Medtentia International Ltd Oy|A device and method for improving the function of a heart valve|

---

US8167932B2|2005-10-18|2012-05-01|Edwards Lifesciences Corporation|Heart valve delivery system with valve catheter|

---

US8449606B2|2005-10-26|2013-05-28|Cardiosolutions, Inc.|Balloon mitral spacer|

---

US7785366B2|2005-10-26|2010-08-31|Maurer Christopher W|Mitral spacer|

---

US8778017B2|2005-10-26|2014-07-15|Cardiosolutions, Inc.|Safety for mitral valve implant|

---

US8764820B2|2005-11-16|2014-07-01|Edwards Lifesciences Corporation|Transapical heart valve delivery system and method|

---

CA2631662C|2005-12-07|2014-08-05|Arbor Surgical Technologies, Inc.|Connection systems for two piece prosthetic heart valve assemblies|

---

US20070213813A1|2005-12-22|2007-09-13|Symetis Sa|Stent-valves for valve replacement and associated methods and systems for surgery|

---

US9078781B2|2006-01-11|2015-07-14|Medtronic, Inc.|Sterile cover for compressible stents used in percutaneous device delivery systems|

---

CN101415379B|2006-02-14|2012-06-20|萨德拉医学公司|Systems for delivering a medical implant|

---

US8147541B2|2006-02-27|2012-04-03|Aortx, Inc.|Methods and devices for delivery of prosthetic heart valves and other prosthetics|

---

US8219229B2|2006-03-02|2012-07-10|Edwards Lifesciences Corporation|Virtual heart valve|

---

EP2004095B1|2006-03-28|2019-06-12|Medtronic, Inc.|Prosthetic cardiac valve formed from pericardium material and methods of making same|

---

US7737060B2|2006-03-31|2010-06-15|Boston Scientific Scimed, Inc.|Medical devices containing multi-component fibers|

---

JP5016667B2|2006-04-29|2012-09-05|メドトロニック，インコーポレイテッド|Multi-membered prosthetic heart valve assembly, apparatus using the same, and method of using the same|

---

US8449605B2|2006-06-28|2013-05-28|Kardium Inc.|Method for anchoring a mitral valve|

---

US20080021546A1|2006-07-18|2008-01-24|Tim Patz|System for deploying balloon-expandable heart valves|

---

US9814611B2|2007-07-31|2017-11-14|Edwards Lifesciences Cardiaq Llc|Actively controllable stent, stent graft, heart valve and method of controlling same|

---

US9566178B2|2010-06-24|2017-02-14|Edwards Lifesciences Cardiaq Llc|Actively controllable stent, stent graft, heart valve and method of controlling same|

---

US8029556B2|2006-10-04|2011-10-04|Edwards Lifesciences Corporation|Method and apparatus for reshaping a ventricle|

---

SE530568C2|2006-11-13|2008-07-08|Medtentia Ab|Medical device for improving function of heart valve, has flange unit connected to loop-shaped support and provided to be arranged against annulus when loop shaped support abut heart valve|

---

US7655034B2|2006-11-14|2010-02-02|Medtronic Vascular, Inc.|Stent-graft with anchoring pins|

---

US7832251B2|2006-11-15|2010-11-16|Abbott Laboratories|Patterned mold for medical device|

---

US8236045B2|2006-12-22|2012-08-07|Edwards Lifesciences Corporation|Implantable prosthetic valve assembly and method of making the same|

---

JP2012521222A|2009-03-19|2012-09-13|ミリピードリミテッドライアビリティーカンパニー|Reconstruction of cardiac features|

---

US20100168844A1|2007-01-26|2010-07-01|3F Therapeutics, Inc.|Methods and systems for reducing paravalvular leakage in heart valves|

---

US20080183271A1|2007-01-31|2008-07-31|Abbott Laboratories|Compliant crimping sheath|

---

US20080208327A1|2007-02-27|2008-08-28|Rowe Stanton J|Method and apparatus for replacing a prosthetic valve|

---

US7896915B2|2007-04-13|2011-03-01|Jenavalve Technology, Inc.|Medical device for treating a heart valve insufficiency|

---

FR2915087B1|2007-04-20|2021-11-26|Corevalve Inc|IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT.|

---

US8002817B2|2007-05-04|2011-08-23|Abbott Cardiovascular Systems Inc.|Stents with high radial strength and methods of manufacturing same|

---

US20080294230A1|2007-05-24|2008-11-27|Cook Incorporated|Apparatus and methods for deploying self-expanding stents|

---

US20080294248A1|2007-05-25|2008-11-27|Medical Entrepreneurs Ii, Inc.|Prosthetic Heart Valve|

---

JP5367700B2|2007-06-04|2013-12-11|セントジュードメディカルインコーポレイテッド|Prosthetic heart valve|

---

US9827093B2|2011-10-21|2017-11-28|Edwards Lifesciences Cardiaq Llc|Actively controllable stent, stent graft, heart valve and method of controlling same|

---

ES2384199T3|2007-08-24|2012-07-02|St. Jude Medical, Inc.|Prosthetic aortic heart valves|

---

WO2009042196A2|2007-09-26|2009-04-02|St. Jude Medical, Inc.|Collapsible prosthetic heart valves|

---

WO2009053497A1|2007-10-25|2009-04-30|Symetis Sa|Stents, valved-stents and methods and systems for delivery thereof|

---

PL3494930T3|2007-12-14|2020-05-18|Edwards Lifesciences Corporation|Leaflet attachment frame for a prosthetic valve|

---

EP2072027B1|2007-12-21|2020-06-17|Medtentia International Ltd Oy|pre-annuloplasty device and method|

---

CA2714062A1|2008-01-24|2009-07-30|Medtronic, Inc.|Stents for prosthetic heart valves|

---

EP2293745A1|2008-04-18|2011-03-16|Cook Incorporated|Branched vessel prosthesis|

---

US20090276040A1|2008-05-01|2009-11-05|Edwards Lifesciences Corporation|Device and method for replacing mitral valve|

---

US9061119B2|2008-05-09|2015-06-23|Edwards Lifesciences Corporation|Low profile delivery system for transcatheter heart valve|

---

ES2386239T3|2008-05-16|2012-08-14|Sorin Biomedica Cardio S.R.L.|Atraumatic cardiovalvular prosthesis|

---

US8291570B2|2008-05-30|2012-10-23|Boston Scientific Scimed, Inc.|Methods for abluminally coating medical devices|

---

CN202568532U|2008-06-06|2012-12-05|爱德华兹生命科学公司|Implantable artificial valve|

---

US8323335B2|2008-06-20|2012-12-04|Edwards Lifesciences Corporation|Retaining mechanisms for prosthetic valves and methods for using|

---

EP3520737A1|2008-07-15|2019-08-07|St. Jude Medical, LLC|Collapsible and re-expandable prosthetic heart valve cuff designs and complementary technological applications|

---

CN102245129B|2008-07-21|2015-03-18|詹妮弗·K·怀特|Repositionable endoluminal support structure and its applications|

---

US8652202B2|2008-08-22|2014-02-18|Edwards Lifesciences Corporation|Prosthetic heart valve and delivery apparatus|

---

US8287591B2|2008-09-19|2012-10-16|Edwards Lifesciences Corporation|Transformable annuloplasty ring configured to receive a percutaneous prosthetic heart valve implantation|

---

WO2010037141A1|2008-09-29|2010-04-01|Cardiaq Valve Technologies, Inc.|Heart valve|

---

EP3613383A1|2008-11-21|2020-02-26|Percutaneous Cardiovascular Solutions Pty Limited|Heart valve prosthesis|

---

US9011530B2|2008-12-22|2015-04-21|Valtech Cardio, Ltd.|Partially-adjustable annuloplasty structure|

---

CN102341063B|2008-12-22|2015-11-25|瓦尔泰克卡迪欧有限公司|Adjustable annuloplasty device and governor motion thereof|

---

US8348997B2|2009-02-24|2013-01-08|Medtronic Vascular, Inc.|One-way replacement valve|

---

CA2756049C|2009-04-15|2017-05-02|Impala, Inc.|Vascular implant and delivery system|

---

US20100312333A1|2009-04-29|2010-12-09|The Cleveland Clinic Foundation|Apparatus and method for replacing a diseased cardiac valve|

---

US8075611B2|2009-06-02|2011-12-13|Medtronic, Inc.|Stented prosthetic heart valves|

---

US8348998B2|2009-06-26|2013-01-08|Edwards Lifesciences Corporation|Unitary quick connect prosthetic heart valve and deployment system and methods|

---

US8475522B2|2009-07-14|2013-07-02|Edwards Lifesciences Corporation|Transapical delivery system for heart valves|

---

US10034748B2|2009-09-18|2018-07-31|The Regents Of The University Of California|Endovascular prosthetic heart valve replacement|

---

US8377115B2|2009-11-16|2013-02-19|Medtronic Vascular, Inc.|Implantable valve prosthesis for treating venous valve insufficiency|

---

US8449599B2|2009-12-04|2013-05-28|Edwards Lifesciences Corporation|Prosthetic valve for replacing mitral valve|

---

US8795354B2|2010-03-05|2014-08-05|Edwards Lifesciences Corporation|Low-profile heart valve and delivery system|

---

WO2011109813A2|2010-03-05|2011-09-09|Edwards Lifesciences Corporation|Retaining mechanisms for prosthetic valves|

---

US8657872B2|2010-07-19|2014-02-25|Jacques Seguin|Cardiac valve repair system and methods of use|

---

US20120053680A1|2010-08-24|2012-03-01|Bolling Steven F|Reconfiguring Heart Features|

---

EP2611391B1|2010-09-01|2017-11-22|Mvalve Technologies Ltd.|Cardiac valve support structure|

---

AU2011299232A1|2010-09-07|2013-05-02|Paul A. Spence|Cannula systems and methods|

---

US8641757B2|2010-09-10|2014-02-04|Edwards Lifesciences Corporation|Systems for rapidly deploying surgical heart valves|

---

US8652203B2|2010-09-23|2014-02-18|Cardiaq Valve Technologies, Inc.|Replacement heart valves, delivery devices and methods|

---

CN105380730B|2010-10-05|2018-08-17|爱德华兹生命科学公司|Heart valve prosthesis|

---

EP3669829B1|2010-10-05|2021-09-15|Edwards Lifesciences Corporation|Prosthetic heart valve|

---

JP6010545B2|2010-12-23|2016-10-19|トゥエルヴ， インコーポレイテッド|System for mitral valve repair and replacement|

---

US8888843B2|2011-01-28|2014-11-18|Middle Peak Medical, Inc.|Device, system, and method for transcatheter treatment of valve regurgitation|

---

US8945209B2|2011-05-20|2015-02-03|Edwards Lifesciences Corporation|Encapsulated heart valve|

---

US9364326B2|2011-06-29|2016-06-14|Mitralix Ltd.|Heart valve repair devices and methods|

---

US8795357B2|2011-07-15|2014-08-05|Edwards Lifesciences Corporation|Perivalvular sealing for transcatheter heart valve|

---

US20130331929A1|2011-09-09|2013-12-12|Endoluminal Sciences Pty Ltd.|Means for Controlled Sealing of Endovascular Devices|

---

US20130190857A1|2011-09-09|2013-07-25|Endoluminal Sciences Pty Ltd.|Means for controlled sealing of endovascular devices|

---

EP2591755A1|2011-11-12|2013-05-15|Medtentia International Ltd Oy|Device and method for improving fixation of a medical device|

---

CN111870396A|2011-12-09|2020-11-03|爱德华兹生命科学公司|Prosthetic heart valve with improved commissural support|

---

US9078747B2|2011-12-21|2015-07-14|Edwards Lifesciences Corporation|Anchoring device for replacing or repairing a heart valve|

---

EP2620125B1|2012-01-24|2017-10-11|Medtentia International Ltd Oy|An arrangement, a loop-shaped support, a prosthetic heart valve and a method of repairing or replacing a native heart valve|

---

EP3705091A3|2012-01-31|2020-10-21|Mitral Valve Technologies Sàrl|Mitral valve docking devices, systems and methods|

---

US20130304197A1|2012-02-28|2013-11-14|Mvalve Technologies Ltd.|Cardiac valve modification device|

---

US20130274873A1|2012-03-22|2013-10-17|Symetis Sa|Transcatheter Stent-Valves and Methods, Systems and Devices for Addressing Para-Valve Leakage|

---

JP5607695B2|2012-09-13|2014-10-15|ファナック株式会社|Machine tool thermal displacement compensation device|

---

WO2014081796A1|2012-11-21|2014-05-30|Edwards Lifesciences Corporation|Retaining mechanisms for prosthetic heart valves|

---

US9132007B2|2013-01-10|2015-09-15|Medtronic CV Luxembourg S.a.r.l.|Anti-paravalvular leakage components for a transcatheter valve prosthesis|

---

US9439763B2|2013-02-04|2016-09-13|Edwards Lifesciences Corporation|Prosthetic valve for replacing mitral valve|

---

US8986375B2|2013-03-12|2015-03-24|Medtronic, Inc.|Anti-paravalvular leakage component for a transcatheter valve prosthesis|

---

US9636222B2|2013-03-12|2017-05-02|St. Jude Medical, Cardiology Division, Inc.|Paravalvular leak protection|

---

CN107184292B|2013-03-13|2020-07-10|爱德华兹生命科学卡迪尔克有限责任公司|Articulating commissure valve stents and methods|

---

US9326856B2|2013-03-14|2016-05-03|St. Jude Medical, Cardiology Division, Inc.|Cuff configurations for prosthetic heart valve|

---

EP2991585A1|2013-05-03|2016-03-09|Medtronic Inc.|Medical devices for implanting in a valve and associated methods|

---

JP6515088B2|2013-05-20|2019-05-15|エドワーズ ライフサイエンシーズ コーポレイションＥｄｗａｒｄｓ Ｌｉｆｅｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ|Prosthetic heart valve delivery device|

---

EP2805695A1|2013-05-21|2014-11-26|Medtentia International Ltd Oy|Medical system for annuloplasty|

---

CN105682610B|2013-08-12|2017-11-03|米特拉尔维尔福科技有限责任公司|Apparatus and method for being implanted into replacement heart valve|

---

LT3545906T|2013-08-14|2021-03-10|Mitral Valve Technologies Sarl|Replacement heart valve apparatus|

---

WO2015038458A1|2013-09-12|2015-03-19|St. Jude Medical, Cardiology Division, Inc.|Stent designs for prosthetic heart valves|

---

CA2934975A1|2013-11-11|2015-05-14|Edwards Lifesciences Cardiaq Llc|Systems and methods for manufacturing a stent frame|

---

US9622863B2|2013-11-22|2017-04-18|Edwards Lifesciences Corporation|Aortic insufficiency repair device and method|

---

US10098734B2|2013-12-05|2018-10-16|Edwards Lifesciences Corporation|Prosthetic heart valve and delivery apparatus|

---

CA2939618A1|2014-02-18|2015-08-27|Medtentia International Ltd Oy|Medical device for a cardiac valve implant|

---

SG11201606836TA|2014-02-20|2016-09-29|Mitral Valve Technologies Sarl|Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device|

---

US9700412B2|2014-06-26|2017-07-11|Mitralix Ltd.|Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices|

---

US20170273788A1|2014-09-08|2017-09-28|Medtentia International Ltd Oy|Annuloplasty Implant|

---

US10016272B2|2014-09-12|2018-07-10|Mitral Valve Technologies Sarl|Mitral repair and replacement devices and methods|

---

US10039637B2|2015-02-11|2018-08-07|Edwards Lifesciences Corporation|Heart valve docking devices and implanting methods|

---

US9974650B2|2015-07-14|2018-05-22|Edwards Lifesciences Corporation|Prosthetic heart valve|

---

US11096781B2|2016-08-01|2021-08-24|Edwards Lifesciences Corporation|Prosthetic heart valve|

---

US10603165B2|2016-12-06|2020-03-31|Edwards Lifesciences Corporation|Mechanically expanding heart valve and delivery apparatus therefor|

---

US11135056B2|2017-05-15|2021-10-05|Edwards Lifesciences Corporation|Devices and methods of commissure formation for prosthetic heart valve|

---

US10869759B2|2017-06-05|2020-12-22|Edwards Lifesciences Corporation|Mechanically expandable heart valve|US8323335B2|2008-06-20|2012-12-04|Edwards Lifesciences Corporation|Retaining mechanisms for prosthetic valves and methods for using|

---

WO2011109813A2|2010-03-05|2011-09-09|Edwards Lifesciences Corporation|Retaining mechanisms for prosthetic valves|

---

US8657872B2|2010-07-19|2014-02-25|Jacques Seguin|Cardiac valve repair system and methods of use|

---

EP2595569A4|2010-07-23|2016-02-24|Edwards Lifesciences Corp|Retaining mechanisms for prosthetic valves|

---

AU2012299311B2|2011-08-11|2016-03-03|Tendyne Holdings, Inc.|Improvements for prosthetic valves and related inventions|

---

US9078747B2|2011-12-21|2015-07-14|Edwards Lifesciences Corporation|Anchoring device for replacing or repairing a heart valve|

---

EP3705091A3|2012-01-31|2020-10-21|Mitral Valve Technologies Sàrl|Mitral valve docking devices, systems and methods|

---

US11259923B2|2013-03-14|2022-03-01|Jc Medical, Inc.|Methods and devices for delivery of a prosthetic valve|

---

CN105682610B|2013-08-12|2017-11-03|米特拉尔维尔福科技有限责任公司|Apparatus and method for being implanted into replacement heart valve|

---

LT3545906T|2013-08-14|2021-03-10|Mitral Valve Technologies Sarl|Replacement heart valve apparatus|

---

US10195028B2|2013-09-10|2019-02-05|Edwards Lifesciences Corporation|Magnetic retaining mechanisms for prosthetic valves|

---

US9622863B2|2013-11-22|2017-04-18|Edwards Lifesciences Corporation|Aortic insufficiency repair device and method|

---

US10478290B2|2013-11-26|2019-11-19|Children's Medical Center Corporation|Expandable stent valve|

---

SG11201606836TA|2014-02-20|2016-09-29|Mitral Valve Technologies Sarl|Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device|

---

MX2016010303A|2014-02-21|2017-04-27|Mitral Valve Tech Sarl|Devices, systems and methods for delivering a prosthetic mitral valve and anchoring device.|

---

US10016272B2|2014-09-12|2018-07-10|Mitral Valve Technologies Sarl|Mitral repair and replacement devices and methods|

---

US10231834B2|2015-02-09|2019-03-19|Edwards Lifesciences Corporation|Low profile transseptal catheter and implant system for minimally invasive valve procedure|

---

US10039637B2|2015-02-11|2018-08-07|Edwards Lifesciences Corporation|Heart valve docking devices and implanting methods|

---

US10034747B2|2015-08-27|2018-07-31|Medtronic Vascular, Inc.|Prosthetic valve system having a docking component and a prosthetic valve component|

---

CN108992210B|2015-11-06|2021-08-27|麦克尔有限公司|Mitral valve prosthesis|

---

WO2017125170A1|2016-01-22|2017-07-27|Medtentia International Ltd Oy|Annuloplasty implant|

---

US10363130B2|2016-02-05|2019-07-30|Edwards Lifesciences Corporation|Devices and systems for docking a heart valve|

---

USD867595S1|2017-02-01|2019-11-19|Edwards Lifesciences Corporation|Stent|

---

US10470877B2|2016-05-03|2019-11-12|Tendyne Holdings, Inc.|Apparatus and methods for anterior valve leaflet management|

---

CR20190069A|2016-08-26|2019-05-14|Edwards Lifesciences Corp|Heart valve docking coils and systems|

---

US10828150B2|2016-07-08|2020-11-10|Edwards Lifesciences Corporation|Docking station for heart valve prosthesis|

---

US11026782B2|2016-08-11|2021-06-08|4C Medical Technologies, Inc.|Heart chamber prosthetic valve implant with elevated valve section and single chamber anchoring for preservation, supplementation and/or replacement of native valve function|

---

US10722359B2|2016-08-26|2020-07-28|Edwards Lifesciences Corporation|Heart valve docking devices and systems|

---

USD890333S1|2017-08-21|2020-07-14|Edwards Lifesciences Corporation|Heart valve docking coil|

---

US10357361B2|2016-09-15|2019-07-23|Edwards Lifesciences Corporation|Heart valve pinch devices and delivery systems|

---

CN113288514A|2016-12-16|2021-08-24|爱德华兹生命科学公司|Deployment systems, tools, and methods for delivering anchoring devices for prosthetic valves|

---

US10813749B2|2016-12-20|2020-10-27|Edwards Lifesciences Corporation|Docking device made with 3D woven fabric|

---

EP3906893A1|2016-12-20|2021-11-10|Edwards Lifesciences Corporation|Systems and mechanisms for deploying a docking device for a replacement heart valve|

---

US11013600B2|2017-01-23|2021-05-25|Edwards Lifesciences Corporation|Covered prosthetic heart valve|

---

US11185406B2|2017-01-23|2021-11-30|Edwards Lifesciences Corporation|Covered prosthetic heart valve|

---

ES2779850T3|2017-04-28|2020-08-20|Medtentia Int Ltd Oy|Annuloplasty implant|

---

US10842619B2|2017-05-12|2020-11-24|Edwards Lifesciences Corporation|Prosthetic heart valve docking assembly|

---

WO2019081777A1|2017-10-27|2019-05-02|Medtentia International Ltd Oy|Annuloplasty implant|

---

EP3476366B1|2017-10-27|2020-12-16|Medtentia International Ltd Oy|Annuloplasty implant|

---

CN211213690U|2018-01-07|2020-08-11|苏州杰成医疗科技有限公司|Control unit for controlling a valve delivery device to deliver a valve prosthesis|

---

EP3796876A1|2018-05-22|2021-03-31|Boston Scientific Scimed, Inc.|Percutaneous papillary muscle relocation|

---

WO2020073050A1|2018-10-05|2020-04-09|Shifamed Holdings, Llc|Prosthetic cardiac valve devices, systems, and methods|

---

CN111110400B|2019-12-09|2022-02-22|先健科技有限公司|Heart valve tether and have its heart valve subassembly|

---

US20210267755A1|2020-02-27|2021-09-02|Cephea Valve Technologies, Inc.|Valve Retention Supplemented with a Wire Hoop|

---

WO2021178560A1|2020-03-03|2021-09-10|Shifamed Holdings, Llc|Prosthetic cardiac valve devices, systems, and methods|

法律状态:
2020-03-17| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|

---

2021-04-20| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|

---

2021-05-25| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/08/2014, OBSERVADAS AS CONDICOES LEGAIS. |

优先权:

---

申请号 | 申请日 | 专利标题

---

US201361864860P| true| 2013-08-12|2013-08-12|

---

US61/864,860|2013-08-12|

---

US201361867287P| true| 2013-08-19|2013-08-19|

---

US61/867,287|2013-08-19|

---

US201361878280P| true| 2013-09-16|2013-09-16|

---

US61/878,280|2013-09-16|

---

PCT/US2014/050525|WO2015023579A1|2013-08-12|2014-08-11|Apparatus and methods for implanting a replacement heart valve|

---